Halogenated organic molecules of Rhodomelaceae origin: chemisty and biology by Bin-Gui Wang* et al.
Halogenated Organic Molecules of Rhodomelaceae Origin:
Chemistry and Biology
Bin-Gui Wang,*,† James B. Gloer,‡ Nai-Yun Ji,§ and Jian-Chun Zhao†
†Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, P. R.
China
‡Department of Chemistry, University of Iowa, Iowa City, Iowa 52242, United States
§Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai 264003, P. R. China
*S Supporting Information
CONTENTS
1. Introduction 3633
2. Reviews 3633
3. Classiﬁcation 3634
4. Structure and Occurrence 3634
4.1. Halogenated Monoterpenes 3634
4.2. Halogenated Sesquiterpenes 3634
4.2.1. Bisabolane Sesquiterpenes 3634
4.2.2. Brasilane Sesquiterpenes 3635
4.2.3. Chamigrane Sesquiterpenes 3635
4.2.4. Cuparane Sesquiterpenes 3636
4.2.5. Eudesmane and 6,8-Cycloeudesmane
Sesquiterpenes 3636
4.2.6. Laurane and Cyclolaurane Sesquiter-
penes 3637
4.2.7. Snyderane Sesquiterpenes 3637
4.2.8. Sesquiterpenes with New Carbon Skel-
etons 3638
4.2.9. Miscellaneous Sesquiterpenes 3641
4.2.10. Summary of the Occurrence of Halo-
genated Sesquiterpenes 3642
4.3. Halogenated Diterpenes 3642
4.3.1. Irieane Diterpenes 3643
4.3.2. Labdane Diterpenes 3643
4.3.3. Parguerane, Isoparguerane, Neopar-
guerane, and Pimarane Diterpenes 3643
4.3.4. Miscellaneous Diterpenes with New or
Rarely Reported Skeletons 3644
4.4. Halogenated Triterpenes/Polyethers 3644
4.4 .1 . Tr i terpenes Possess ing a 2,7-
Dioxabicyclo[4.4.0]decane Skeleton 3645
4.4 .2 . Tr i terpenes Possess ing a 2,8-
Dioxabicyclo[5.4.0]undecane Skeleton 3646
4.4.3. Triterpenes Possessing Symmetric Ele-
ment(s) 3646
4.5. Halogenated Nonterpenoid C15-Acetogenins
(ACGs) 3646
4.5.1. Linear ACGs 3647
4.5.2. ACGs of the Five-Membered Cyclic
Ether Class (Tetrahydrofuran ACGs,
THF ACGs) 3647
4.5.3. ACGs of the Bis-Tetrahydrofuran Class
(Bis-THF ACGs) 3647
4.5.4. ACGs of the 2,6-Dioxabicyclo[3.3.0]-
octane Class 3648
4.5.5. ACGs of the Six-Membered Cyclic Ether
Class (Tetrahydropyran ACGs, THP
ACGs) 3649
4.5.6. ACGs of the 2,7-Dioxabicyclo[4.3.0]-
nonane Class 3649
4.5.7. ACGs of the Seven-Membered Cyclic
Ether Class 3649
4.5.8. ACGs of the Eight-Membered Cyclic
Ether Class 3649
4.5.9. ACGs of the Nine- and Ten-Membered
Cyclic Ether Classes 3650
4.5.10. ACGs of the Twelve-Membered Cyclic
Ether Class 3651
4.5.11. ACGs of the Maneonene and Isoma-
neonene Classes 3652
4.5.12. Branched ACGs 3653
4.5.13. Miscellaneous ACGs 3653
4.6. Halogenated Indoles 3653
4.7. Halogenated Phenols/Aromatics 3653
4.8. Other Halogenated Organic Molecules 3654
4.9. Summary to the Occurrence of Halogenated
Organic Molecules 3654
5. Chemotaxonomic Signiﬁcance 3656
6. Synthesis 3658
6.1. Synthesis of Sesquiterpenes 3658
Received: June 15, 2009
Published: March 1, 2013
Review
pubs.acs.org/CR
© 2013 American Chemical Society 3632 dx.doi.org/10.1021/cr9002215 | Chem. Rev. 2013, 113, 3632−3685
6.1.1. Synthesis of Chamigrane Sesquiter-
penes 3658
6.1.2. Synthesis of Laurane and Snyderane
Sesquiterpenes 3659
6.1.3. Synthesis of Sesquiterpenes with New
Carbon Skeletons 3660
6.2. Synthesis of Diterpenes 3660
6.3. Synthesis of Triterpenes 3661
6.3.1. Synthesis of Thyrsiferol and Its Deriva-
tives 3661
6.3.2. Synthesis of (+)-Intricatetraol 3662
6.4. Synthesis of C15-Acetogenins (ACGs) 3662
6.4.1. Synthesis of ACGs Containing Tetrahy-
drofuran Structural Units 3665
6.4.2. Synthesis of Seven-Membered Cyclic
ACGs 3666
6.4.3. Synthesis of ACGs Containing Eight-
Membered Cyclic Ether Cores 3667
6.4.4. Synthesis of ACGs Containing Nine-
Membered Cyclic Ether Cores 3669
6.4.5. Synthesis of Maneonene and Isomaneo-
nene ACGs 3669
6.5. Synthesis of Bromoindoles 3669
6.6. Synthesis of Bromophenols 3670
7. Biosynthesis 3670
7.1. Biosynthesis of Sesquiterpenes 3670
7.2. Biosynthesis of C15-Acetogenins 3671
8. Biological Activities and Functions 3672
8.1. Biological Activities 3672
8.1.1. Cytotoxic Activity 3672
8.1.2. Antibacterial Activity 3673
8.1.3. Antifungal Activity 3674
8.1.4. Antiviral Activity 3674
8.1.5. Enzyme−Inhibitory Activity 3674
8.1.6. Radical Scavenging Activity 3674
8.2. Biological Functions 3675
8.2.1. Antifeedant Activity 3675
8.2.2. Insecticidal Activity 3675
8.2.3. Antifouling Activity 3675
8.2.4. Allelopathic Activity 3675
8.3. Miscellaneous Activity 3675
8.4. Summary of Biological Activities and Func-
tions 3676
9. Prospects for Future Discoveries and Concluding
Remarks 3676
Associated Content 3676
Supporting Information 3676
Author Information 3676
Corresponding Author 3676
Notes 3676
Biographies 3677
Acknowledgments 3678
Abbreviations 3678
References 3678
1. INTRODUCTION
It is sometimes assumed that halogenated organic molecules,
organic chemicals containing one or more carbon−chlorine,
carbon−bromine, carbon−iodine, or carbon−ﬂuorine bonds,
are generally rare in nature.1 For example, the presence of
bromine as an algal constituent in some form has long been
recognized. As early as the 1920s, many algae were known to
concentrate it, but the chemical nature of the accumulated
bromine was the subject of some dispute.2 Eventually, studies
of Polysiphonia fastigiata (also known as P. lanosa), a marine red
algal species of the family Rhodomelaceae, provided unequiv-
ocal evidence for covalently bound bromine in algae.2 More
recent studies indicated that halogenated natural products are
actually common in some sources. In fact, more than 5000
halogenated natural products had been discovered as of 2011.3
The Rhodomelaceae (order Ceramiales, class Rhodophyceae,
and phylum Rhodophycota) is estimated to be the largest
marine red algal family, with about 125 genera and some 700
species recognized worldwide.4 Chemical investigations of
species of this family have resulted in the isolation and
structure elucidation of many interesting halogenated mole-
cules. According to a recently released version of MarinLit
(version vpc 15.5, March 2012), a marine literature database
produced and maintained by the Department of Chemistry,
University of Canterbury, New Zealand,5 a total of 1058
naturally occurring compounds were isolated and characterized
from species in the Rhodomelaceae from the 1960s until early
2012. Of these, 808 (76%) were halogenated (760 brominated,
262 chlorinated, 218 brominated and chlorinated, and 4
iodinated). These molecules account for 20% of the 4079
halogenated compounds that were characterized from all
marine organisms during this period.5
Halogen-containing organic molecules from the Rhodome-
laceae represent unique secondary metabolites in terms of
structural and biological diversity, and the widespread
occurrence of such compounds in these organisms has
implications for their potential ecological signiﬁcance. The
biodiversity of algal species of this family provided a useful
resource for extending the chemodiversity of known
halogenated molecules, as well as for ﬁnding new interesting
structures for medicinal chemistry studies.
This review attempts to give a comprehensive survey and
highlight the diversity of halogenated organic molecules
produced by marine red algal species in the family
Rhodomelaceae. A total of 697 structures published up to the
end of 2011 are included and 525 references are cited in this
review. However, simple halogenated hydrocarbons, phenols,
and volatile organic molecules are generally not included. It
should be noted that some of the earliest reports of structures
of this type unfortunately contained limited spectroscopic data
and lacked ﬁrm evidence for the proposed stereochemistry. In
addition, the collection sites for some of the studied algal
materials were not described in some reports. While every eﬀort
was made to be comprehensive within the topic, we apologize
in advance for any oversights.
2. REVIEWS
Although no review on the many halogenated molecules
derived from marine red algae of the family Rhodomelaceae
appeared in the literature up to now, a number of excellent
reviews on various aspects of naturally occurring halogenated
molecules were published. A series of excellent reviews by
Gribble provided an extensive coverage of various halogenated
organic compounds of both biotic and abiotic origin.1,3,6−16
Speciﬁc classes of compounds are evaluated in “Halogenated
and/or sulfated phenols from marine macroalgae”17 and
“Natural halogenated fatty acids: their analogues and
derivatives”.18 Other related topics reviewed are “Nature’s
inventory of halogenation catalysts: oxidative strategies
predominate”,3 “Marine haloperoxidases”,19 “Halogenated
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metabolites from marine animals and plants”,20 and “Halogen-
ation in the Rhodophyta”.21 A series of timely reviews entitled
“Marine natural products” provided comprehensive surveys of
all natural products that were isolated and reported from
marine resources annually.22,23 In addition to the above listed
reviews, a book chapter entitled “Constituents of Laurencia”
appeared in 198324 and provided a consolidated review
covering all types of compounds, both halogenated and
nonhalogenated, reported from species of the genus Laurencia,
the most heavily studied algal genus within the family
Rhodomelaceae. However, none of the above-mentioned
reviews provided a full-aspect and in-depth view on the array
of halogenated organic molecules from the algal family
Rhodomelaceae. The present review aims to give a
comprehensive coverage of all naturally occurring halogenated
organic molecules of the Rhodomelaceae origin and to provide
a general overview of both chemical and biological aspects of
these compounds. In general, the occurrence/distribution and
structure/substitution features, as well as the chemotaxonomic
signiﬁcance of these molecules are discussed. Approaches
toward the synthesis and biosynthesis of these halogenated
organic molecules, especially studies employing a new method-
ology or a new strategy, are summarized. Biological activities
and potential functions of these molecules are also discussed.
3. CLASSIFICATION
Halogenated molecules can most simply be classiﬁed as
ﬂuorinated, chlorinated, brominated, or iodinated compounds.
Most halogenated compounds of Rhodomelaceae origin are
brominated or chlorinated. Only four were iodinated and no
ﬂuorinated compounds were discovered from these sources to
date. Since most of these compounds contain only bromine or
chlorine atoms, it is not particularly useful to classify the
halogenated compounds only according to the halogen they
contain. Instead, the halogenated organic molecules from the
family Rhodomelaceae are generally categorized in this review
on the basis of their structural characteristics into terpenoids,
nonterpenoid C15-acetogenins (ACGs), indoles, and phenols/
aromatics. The halogenated terpenoids, nonterpenoid ACGs,
and indoles were mainly discovered from the genus Laurencia,
while the halogenated phenols/aromatics were reported
primarily as metabolites from other genera of the family, such
as Polysiphonia, Rhodomela, and Symphyocladia.
4. STRUCTURE AND OCCURRENCE
4.1. Halogenated Monoterpenes
Although algal species of the family Rhodomelaceae were the
most proliﬁc producers of halogenated organic molecules, up to
date no halogenated monoterpene was reported from a
member of this family. Thus far, the isolation of halogenated
monoterpenes is restricted to two families of marine red algae,
the Plocamiaceae and Rhizophyllidaceae.25
4.2. Halogenated Sesquiterpenes
Species of the Rhodomelaceae especially from the genus
Laurencia, produce sesquiterpenoids, either regular or irregular,
in far greater numbers than any other structural class of
secondary metabolites. Up to now, 275 halogenated sesqui-
terpenes (1−275, Figures 1−19) were identiﬁed as metabolites
of Rhodomelaceae. Detailed and tabulated information for each
of these halosesquiterpenes, including compound name
(synonym, if applicable), molecular formula, halogenation/
structure features, source species, sample collection locality, and
reference, was provided in Tables S1−S7 in the Supporting
Information.
4.2.1. Bisabolane Sesquiterpenes. Twenty-four halogen-
ated bisabolane sesquiterpenes (1−24, Figure 1 and Supporting
Information Table S1) were identiﬁed from the algal family
Rhodomelaceae, and all of them from the genus Laurencia.26−38
Compounds of this class occurred in seven species including L.
aldingensis,31,32 L. caespitosa,27,33−35,37,38 L. catarinensis,36 L.
composita,28 L. obtusa,26 L. saitoi,30 and L. scoparia.29 These
metabolites are usually characterized by containing mono-
cyclohexanyl motif (1−8), or possessing 6,9-epoxy (9 and 10)
or 7,11-epoxy (11−24) ring system, or having multiple
oxacyclic rings (11−14) in the molecules. With few exceptions
(11−14), these compounds are both brominated and
chlorinated at C2 and C3 and generally possess 2,3-trans-halide
conformation. The structures of these metabolites were mainly
determined by interpretation of spectral data, and the S
conﬁguration at C9 of puertitol B (2) was established by use of
the CD allylic benzoate method.26 For compounds 6, 15−17,
and 23, their structures were conﬁrmed by single-crystal X-ray
crystallographic experiments. Among them, compounds 629 and
1533,34 are remarkable. The X-ray crystallographic analysis of
compound 6 was nontrivial since the allylic-homoallylic system
present in the side chain of 6 was found to be very reactive and
a rapid decomposition was observed upon irradiation.29 To
determine the structure and absolute conﬁguration of all
stereocenters in the molecule, several single crystals were
required and were protected from air by embedding them in a
droplet of wax to reduce the decomposition rate. A complete
Figure 1. Bisabolane sesquiterpenes (1−24).
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data set which is suitable for determining both the structure and
the absolute conﬁguration of the entire molecule was obtained
by combining results from two diﬀerent crystals.29 As for
caespitol (15), it was originally reported as a chamigrane
sesquiterpene as determined by spectroscopic analysis33 but the
structure was subsequently revised to a bisabolane sesquiter-
pene 15 based on the results of X-ray studies of isocaespitol
(23), a coexisting sesquiterpene in the same species of L.
caespitosa, as well as by chemical correlation between the two
isomers.34
4.2.2. Brasilane Sesquiterpenes. To date, only two
papers describing four halogenated brasilane derivatives (25−
28, Figure 2 and Supporting Information Table S1) were
published, with all of them from L. obtusa collected either from
Greece39 or from Turkish waters.40 These sesquiterpenes share
common characteristics of 8-Cl (25, 27, and 28) or 8-Br (26)
halogenation and a 9-OH substitution in the ﬁve-membered
ring, with three of them, 25−27, possessing an unprecedented
1,6-epoxy moiety in the brasilane skeleton.39 While the
structures and relative conﬁgurations of 25−27 were fully
established by means of spectral data analysis along with
molecular modeling calculations,39 the relative stereochemistry
of the various asymmetric centers in 28 could not be
determined.40 However, the magnitude of the vicinal coupling
constants and the four-bond coupling of H-4a and H-2b
indicated that the six-membered ring assumes a regular chair
conformation with the isopropyl group adopting an equatorial
orientation.40
4.2.3. Chamigrane Sesquiterpenes. Halogenated and
spiro-fused sesquiterpenoids containing the spiro[5,5]undecane
skeleton as exempliﬁed by the chamigrane class are the most
frequently encountered types of marine natural products from
the genus Laurencia. Halochamigranes distributed in a wide
range of species of the genus, and four species (L. nidif ica, L.
nipponica, L. majuscula, and L. obtusa) are especially abundant
sources of this class of compounds (Supporting Information
Table S2). A total of 93 halochamigranes (29−121, Figures
3−6 and Supporting Information Table S2), with 33
brominated, 6 chlorinated, and 54 bromochlorinated (with 26
and 28 of them containing BrCl and Br2Cl, respectively), were
described up to the end of 2011.28,30,41−105 On the basis of the
oxidation state at C5 and C10, halochamigranes can be further
divided into two subclasses, that is, with or without a 5,10-
epoxide ring system. Twelve of them (29−40, Figure 3) that
contain a 5,10-epoxide ring system fall into the ﬁrst subclass
and the others (41−121, Figures 4−6), possessing various
halogen- and oxygen-substitution as well as dehydrogenations
at diﬀerent positions in the skeleton, form the second subclass.
Among these, pacifenol (29) was the ﬁrst natural product
reported to contain both Br and Cl in the structure.41 As can be
seen from Figure 3, the bromine atom is usually located on the
secondary carbon (C2) whereas the chlorine is often attached
to the tertiary center (C3) on the opposite face of Br-atom,
representing a characteristic 2,3-trans-halide arrangement
observed for 5,10-epoxychamigrane sesquiterpenes (29−31
and 37−40). This halogenation pattern is also commonly
observed in other chamigrane sesquiterpenes, as shown in
Figures 4−6, which indicates that C2 and C10 are the most
favored positions for Br-substitution, whereas C3 appears to be
favored for Cl-substitution. However, the secondary carbon C2
tends to be the preferred position for the Cl-atom when a
chamigrane sesquiterpene contains Cl as the only halogen atom
in the molecule (56,64 83,80 86,81 109, and 11095). Some other
unique structural features, such as the unusual cis-relationship
of the heteroatoms at C2 and C3 (68
72 and 8581), the unusual
occurrence of halogenation on a double bond (41−43,28,55
52,43 53,62 55,63 56,64 60,67 70, 71,74 83,80 88,30 89,82 92,85 and
94−9849,86−88), and the rare conjugated bromodiene system
(76, 77,76 107, 108,93,94 and 11498), were observed among the
halochamigranes of Laurencia origin.
With regard to structure determination, it should be noted
that NMR spectroscopic techniques are sometimes not enough
to unambiguously determine the positions of the Br and Cl
atoms in chamigranes as well as in other polybromochlorinated
natural products because NMR signals because of protons/
carbons α to oxygen, bromine, and chlorine often occur in the
same region of the spectrum. This is exempliﬁed by the fact
that the locations of Br and Cl atoms in a number of
halochamigranes were misplaced in initial structure assign-
ments.46,69,105 Therefore, the X-ray crystallographic analysis
should be used for structure conﬁrmation of such metabolites,
especially when a new compound with an unprecedented
halogenation pattern is discovered.69 For noncrystalline
compounds, NMR data calculation and comparison with
experimental results, chemical correlation with known com-
pounds, or independent partial or total synthesis can also
Figure 2. Brasilane sesquiterpenes (25−28).
Figure 3. Chamigrane sesquiterpenes (29−40).
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become particularly important for structure determination and
conﬁrmation.
4.2.4. Cuparane Sesquiterpenes. Although a wide variety
of sesquiterpenes were discovered from the algal species of the
family Rhodomelaceae, cuparane sesquiterpenes are occasion-
ally encountered. To date, only seven representatives of this
class (122−128, Figure 7 and Supporting Information Table
S3) were reported from the family, with four of them having Br-
atom at C3 (122−125)
106−108 and three at C10 (126−
128).109,110 α-Bromocuparene (122) and α-isobromocuparene
(123) appeared to be the ﬁrst representatives of cuparane
sesquiterpenes isolated from seaweeds.106 Compound 126
contains a 3,7-epoxy moiety in the molecules, while 127109 and
128110 reﬂect a migration of the C1 methyl group that is
unprecedented among members of the cuparane class of
sesquiterpenes. Cuparane sesquiterpenes were recorded from
ﬁve species of the genus Laurencia including L. glandulifera,106
L. implicata,108 L. majuscula,107 L. microcladia,109 and L.
okamurai.110
4.2.5. Eudesmane and 6,8-Cycloeudesmane Sesqui-
terpenes. Like cuparane sesquiterpenes, eudesmane (seli-
nane), and 6,8-cycloeudesmane sesquiterpenes are also rarely
encountered from these algae. To date, only seven
representatives (129−135, Figure 8 and Supporting Informa-
tion Table S3) were reported from members of the
Rhodomelaceae, mainly from Laurencia f iliformis, L. intricata,
Figure 4. Chamigrane sesquiterpenes (41−65).
Figure 5. Chamigrane sesquiterpenes (66−100).
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and L. microcladia.111−117 Among them, heterocladol (129),
which was characterized in 1977 from L. f iliformis f. heteroclada
collected near Cape Jervis of South Australia, represents the
ﬁrst example of a eudesmane sesquiterpene from the family
Rhodomelaceae.111 Its structure, including absolute conﬁg-
uration, was determined by spectroscopic methods as well as by
an X-ray crystallographic study.111 A similar compound, 1S-
bromo-4R-hydroxy-(−)-selin-7-ene (131), was independently
reported by two groups from unidentiﬁed Laurencia spp. from
the Gulf of California113 and from Australia.114 Eudesmane
sesquiterpenes of Rhodomelace origin display a 1-bromo
substituent, with 129 and 130 containing a Cl-atom at C6
and C7, respectively, while 1-bromo-6,8-cyclo-4-eudesmanol
(135), isolated from L. microcladia collected in the Bay of
Calenzana, Elba Island,117 represents the ﬁrst 6,8-cyclo-
eudesmane sesquiterpene of marine origin.
4.2.6. Laurane and Cyclolaurane Sesquiterpenes. A
total of 30 laurane (136−165)110,118−138 and six cyclolaurane
(166−171)125,126,130,131,137,139,140 sesquiterpenes were identi-
ﬁed from the algal family Rhodomelaceae (Figure 9 and
Supporting Information Table S4). These molecules are
generally constituted by a substituted aromatic/phenyl group
connecting a 1,2,3-trisubstituted cyclopentane moiety, with
only one exception, compound 163, as a nonaromatic triene
obtained from a Spanish specimen of L. pinnatif ida.127 Some of
these sesquiterpenes contain 2,7-epoxy (147−151),110,130−133
3,7-epoxy (152−158,120−123,134,135 161,137 and 162138), 4,7-
epoxy (160),136 or 5,7-epoxy (164)134 units. As for
halogenation, each compound contains a Br-substituent, with
the majority at C10 and/or C12, and three of them display
iodine substitution at C8 (169),
137 C11 (140), and C12
(157).123 The latter two compounds represent the ﬁrst
examples of naturally occurring iodinated sesquiterpenes.123
Laurane and cyclolaurane sesquiterpenes are mainly charac-
terized from the species L. f iliformis,120,134 L. glandulifera,121,122
L. microcladia,137,140 L. nipponica,118 L. okamurai,110,130−132 and
L. tristicha.129,133,135
4.2.7. Snyderane Sesquiterpenes. Following chami-
granes, a total of 38 halogenated snyderane sesquiterpenes
form the next largest major group of halosesquiterpenes
Figure 6. Chamigrane sesquiterpenes (101−121).
Figure 7. Cuparane sesquiterpenes (122−128).
Figure 8. Eudesmane (129−134) and 6,8-cycloeudesmane (135)
sesquiterpenes.
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characterizd from the genus Laurencia (172−209, Figures 10
and 11 and Supporting Information Table S5).72,141−154 These
sesquiterpenes generally contain a cyclohexane or cyclohexene
moiety, with seven (187−193,147−149 Figure 10) and ﬁfteen
(195−209,143,147,149,151−154 Figure 11) of them containing
additional 4,7-epoxy and 2,7-epoxy ring systems, respectively.
3β-Bromo-8-epicaparrapi oxide (194) is the only halogenated
snyderane sesquiterpene having a 3,7-epoxy unit,150 while
luzofuran (193) was the ﬁrst furan-containing derivative to be
encountered among the snyderane-type sesquiterpenes from
the genus Laurencia.149 α-Snyderol (172) and β-snyderol (173)
are the ﬁrst examples of the snyderane class of sesquiterpenes,
and were isolated from L. obtusa collected at Tossa de Mar,
Spain, and L. snyderae collected at La Jolla, California,
respectively,141 while 8-hydroxy-γ-snyderol (180) is the ﬁrst
example of a γ-snyderol derivative isolated from marine
sources144 and 2-bromo-γ-ionone (186) is the only brominated
dinor-snyderane sesquiterpene characterized from Laurencia
species.147 Each of the snyderane derivatives of Laurencia origin
is monobrominated at C10 or dibrominated at C10 and C1, with
only two exceptions, palisol (178)143 and isopalisol (181),145
which are monobrominated at C1. Among the dibromiated
snyderane derivatives, C1 and C10 were the most favored
positions for Br-atoms (182, 183,145 185,146 189−192,148,149
196−198,143 202, 203,149 and 206−209,147,153 Figures 10 and
11). As indicated in Supporting Information Table S5, seven
species were reported to produce snyderane sesquiterpenes,
with L. luzonensis145,148,149 and L. obtusa72,141,142,150 being the
most abundant sources of this compound type.
4.2.8. Sesquiterpenes with New Carbon Skeletons. To
date, thirty-seven diﬀerent sesquiterpenoid carbon skeletons
have been described from members of the algal family
Rhodomelaceae, with twenty of them being new or rare
structural types (see below in section 4.2.10). Four halogenated
acetal derivatives, laureacetals A (210),155,156 B (211),156 D
(212), and E (213),157 which possess a new (secochamigrane)
Figure 9. Laurane (136−165) and cyclolaurane (166−171) sesquiterpenes.
Figure 10. Snyderane sesquiterpenes (172−194).
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carbon skeleton that appears to be generated from a 10-
bromochamigrene derivative by oxidative cleavage of the C1−
C2 bond, followed by acetal formation, were identiﬁed from L.
nipponica collected from Hokkaido, Japan (Figure 12 and
Supporting Information Table S6). While 210 featured two
ﬁve-membered ether rings, 211−213 had a four-membered
ether ring fused to a ﬁve-membered ether ring to form the
acetal. The structure and absolute conﬁguration of 210 were
determined by spectroscopic methods and by X-ray diﬀraction
analysis.155 Bromocyclococanol (214), a sesquiterpene con-
taining fused cyclopropane−cyclopentane rings leading to a
novel carbon skeleton, was discovered from L. obtusa collected
from Cayo Coco, Cuba.158 The trivial name cyclococane was
proposed for the skeleton. Calenzanol (215), a sesquiterpene
possessing the novel calenzanane carbon skeleton, was isolated
as a major metabolite of L. microcladia collected from the Bay
of Calenzana at Elba Island.159 This compound features a fused
3/6/5-membered tricyclic ring system. It was very unstable and
underwent thermal decomposition at 40 °C to give a novel
indene derivative.159 A species of L. subopposita collected at La
Jolla, California, contained the major metabolite oppositol
(216)160 and its two congeners, the epimeric diols 217 and
218,161 which comprise another class of sesquiterpenes having a
novel carbon skeleton (oppositane). Spectral and X-ray
diﬀraction analysis of oppositol 216 led to the determination
of its structure and absolute conﬁguration.160
Perforatone (219, Figure 13 and Supporting Information
Table S6), a sesquiterpene with a new carbon skeleton
(cycloperforane) featuring a fused 4/5/6-membered tricyclic
unit, was obtained from L. perforata collected at the Canary
Islands.162 Following extensive analyses of NOESY correlations,
the stereochemistry of 219 was revised in a recent report, which
also described the structures of four similar compounds 220−
223 from L. obtusa collected at Milos Island in the Aegean Sea,
Greece.163 L. obtusa (Serifos Island in the central Aegean Sea,
Greece) was the source of the sesquiterpene 8-bromo-9,11-
cyclo-4-perforen-3-one (224),140 while L. tenera (Townsville
region of the Great Barrier Reef, Australia) produced 2-epi-
perforatone (225)164 and tenerol acetate (226).165 The
structure of 2-epi-perforatone (225) was determined by
single-crystal X-ray diﬀraction.164
Perforenone B (227)162 and perforenol (228)166 isolated
from L. perforata and perforenol B (229)140 isolated from L.
obtusa were three halosesquiterpenes with a new carbon
skeleton (perforane), which might be derived from perforatone
219 by cleavage of the C1−C9 bond (Figure 14 and Supporting
Information Table S6). L. perforata was also the source of
Figure 11. Snyderane sesquiterpenes (195−209).
Figure 12. Sesquiterpenes with new carbon skeletons (210−218).
Figure 13. Sesquiterpenes with new carbon skeletons (219−226).
Figure 14. Sesquiterpenes with new carbon skeletons (227−230).
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another bromochlorosesquiterpene, perforene (230),167 pos-
sesses another new carbon skeleton (friedoperforane) that
might be derived from the bromocarbenium ion of the
corresponding chamigrene sesquiterpenes through a stereo-
speciﬁc pathway.167 The structures and the relative conﬁg-
urations of these compounds were proposed on the basis of
their spectral data, and the structure of perforenol (228),
including its absolute conﬁguration, was conﬁrmed by X-ray
crystallographic analysis.166
Three new bromochlorosesquiterpenes including rhodolaur-
eol and rhodolauradiol (231 and 232)168 and 1(12)-
isorhodolaureol (233)98 (Figure 15 and Supporting Informa-
tion Table S6), which have a new tricyclic carbon skeleton
(rhodolaurane) not found previously among naturally occurring
terpenoids, were isolated from an unidentiﬁed alga of the genus
Laurencia and from L. majuscula, respectively. Gomerones A−C
(234−236), recently reported from L. majuscula, are new
chlorosesquiterpenes representing a novel tricyclic carbon
skeleton given the name gomerane.169 Both the rhodolaurane
and gomerane skeletons are likely derived from a β-chamigrene
precursor by ring closure from C14 to C3 and C2,
169
respectively. Güimarediol (237) is also a tricyclic bromosesqui-
terpene with a new rearranged isoprenoid skeleton (designated
as güimarane, derived from the location where the seaweed was
collected) and was obtained from a species of the genus
Laurencia collected oﬀ Güimar, Tenerife, Canary Islands,170
while 238 is an additional bromosesquiterpene having a new
tricyclic carbon framework (rearranged cycloperforane) and
was isolated from L. tenera (Townsville, Australia).164 The
crystalline sample of 238 was unstable and the bulk of the
specimen decomposed on storage at −10 °C and thus
precluded a single-crystal X-ray study of this interesting
molecule.164
A specimen of L. nipponica collected oﬀ the Paciﬁc Coast of
Hokkaido contained the minor sesquiterpene laurencial (239,
Figure 16 and Supporting Information Table S6), which
possesses a new spiro[4,5]decane skeleton and α,β-unsaturated
aldehyde moiety.171 The carbon skeleton might be derived
from the chamigrene framework involving with an interesting
modiﬁcation of ring-contraction.171 Spirolaurenone (240),
which possesses a new carbon skeleton (spirolaurane), is
another novel sesquiterpene that is considered to be a ring
contraction product of the corresponding chamigrene epox-
ide,10-bromo-3,4-epoxy-α-chamigrene (44), with which it co-
occurs in the species L. glandulifera.172 Its absolute conﬁg-
uration was established by chemical correlation with
glanduliferol (47), a halo-chamigrene derivative isolated from
the same alga.173 Kylinone (241), which was obtained from L.
pacif ica collected at Stillwater Cove on the Monterey Peninsula,
California and possesses a new spirobicycloundecane skeleton
assigned the trivial name kylinane (in honor of the Swedish
phycologist Kylin, who ﬁrst described L. pacif ica), appears to be
derived from rearrangement of the corresponding chamigrene
epoxide, deoxyprepacifenol (96).174 Other rearranged sesqui-
terpenes (242−248) possessing a new carbon skeleton which
appears to result from a methyl migration from C11 to C10 of
chamigrene framework, were isolated from a new species of the
genus Laurencia (242),101 from L. pinnatif ida (243, pinnati-
fate),175 from L. okamurai (244, laurenokamurin),176 from L.
composita (laurencomposidiene 245 and 2-bromospironippol
246),177 as well as from L. pannosa (pannosanol 247 and
pannosane 248).178 The positions of Br and Cl in 247 were
conﬁrmed by the halogen-induced 13C isotope shifts in the 13C
NMR measurement.178
Eleven halosesquiterpenes (249−259, Figure 17 and
Supporting Information Table S6) representing a new class
of cyclohexylcyclohexane-containing carbon skeleton that may
be rationalized as arising from C11−C14 cyclization of a
bisabolene derivative, were identiﬁed from several species of the
genus Laurencia.179−181 One of them, dibromoether 249, was
isolated from L. obtusa collected at Graciosa Island and its
Figure 15. Sesquiterpenes with new carbon skeletons (231−238).
Figure 16. Sesquiterpenes with new carbon skeletons (239−248).
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structure, including absolute conﬁguration, was determined by
X-ray crystallographic techniques.179 Seven structurally related
compounds, majapolenes A (250) and B (251), majapolone
(255), and majapols A−D (256−259), were obtained from a
Philippine collection of L. majuscula.180 The three congeners
acetylmajapolene A (252), acetylmajapolene B (253), and
tiomanene (254) were recently isolated from an unidentiﬁed
Laurencia species that was collected from Pulau Tioman,
Malaysia.181 With the exceptions of 249, 251, 253, and 254, all
of these compounds were obtained as inseparable diastereo-
meric mixtures. A sample of L. majuscula collected from
Geoﬀrey Bay, Magnetic Island, aﬀorded two new aromatic
sesquiterpenes, 260 and 261, which feature a cyclohexylphenol
ring system that might be derived from C7−C12 cyclization of a
bisabolene derivative, thus representing another previously
undescribed natural occurring carbon skeleton.182
The ﬁrst members of a new class of irregular rearranged
sesquiterpenes related to bisabolanes, laucapyranoids A−C
(262−264, Figure 18 and Supporting Information Table S6),
were obtained from L. caespitosa collected at Punta del Hidalgo,
Tenerife, and near the Island of La Graciosa.35 While the
structure of laucapyranoid B (263) including the absolute
conﬁguration was conﬁrmed by X-ray crystallographic analysis,
the identity of the extremely unstable laucapyranoid C (264)
was established by analysis of its hydrodebrominated
derivatives, whose structures were determined by spectroscopic
analysis and X-ray crystallographic experiment.35
4.2.9. Miscellaneous Sesquiterpenes. In addition to the
halosesquiterpenes discussed above, eleven additional C15 or
C12 terpenoids (265−275, Figure 19 and Supporting
Information Table S7) were also identiﬁed from Laurencia
species.36,71,145,183−188 Among these, majusin (265) is a
halogenated sesquiterpene with a rare cedrene skeleton isolated
from L. majuscula (Xisha Islands, South China Sea),183 while
bromoketone (266) is a rare friedooppositane sesquiterpene
characterized from L. marianensis (the Great Barrier Reef).184
Aristolan-1α-bromo-9β,10β-epoxide (267), isolated from L.
similis (Hainan Islands, China), is the only halogenated
aristolane derivative so far characterized from the genus
Laurencia.185 A cyclic ether, obtusenol (268),186 and an acyclic
bromohydrin-containing sesquiterpene (269)145 were obtained
from L. obtusa (Gökceada Island, Aegean Sea) and from L.
luzonensis (Okinawa), respectively. Two new C12 terpenoids,
furocaespitane (270),187,188 and isofurocaespitane (271),71
considered to be degraded bisabolanes, were isolated from L.
caespitosa and their structures were elucidated by interpretation
of spectral data, while two additional congeners (272 and 273)
were obtained from the same species as minor components.182
The structures of compounds 272 and 273, including their
absolute conﬁgurations, were determined by X-ray diﬀraction
analysis.188 Very recently, two additional C12 terpenoids,
(10R*)- and (10S*)-10-O-methylfurocaespitanelactol (274
and 275), which possess a ketal unit associated with the
butenolide moiety, were characterized from the ﬁrst chemical
Figure 17. Sesquiterpenes with new carbon skeletons (249−261).
Figure 18. Sesquiterpenes with new carbon skeletons (262−264).
Figure 19. Miscellaneous sesquiterpenes/norsesquiterpenes (265−
275).
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investigation of the species L. catarinensis (Santa Catarina,
Brazil). The structure of 274 was conﬁrmed by X-ray
crystallographic analysis.36
4.2.10. Summary of the Occurrence of Halogenated
Sesquiterpenes. The 275 halogenated sesquiterpenes and
norsesquiterpenes (1−275) reported from the Rhodomelaceae,
as discussed above, belong to 10 known (Figure 20, 1−209)
and 21 new/rare carbon skeletons (Figure 21, 210−267). Most
of them consist of fused- or spiro-ring systems (Figures 20 and
21) and their possible biogenetic correlations will be discussed
in section 7.1. In general, compounds with chamigrane,
snyderane, and laurane skeletons are the most frequently
occurring sesquiterpenoid types, respectively accounting for 93
(29−121, 34%), 38 (172−209, 14%), and 36 (136−171, 13%)
of the 275 halogenated sesquiterpenes that were characterized
from marine algal species of the family Rhodomelaceae (Chart
1). On the other hand, only four examples of halogenated
brasilane sesquiterpenes (25−28) and only a single example of
a halogenated 6,8-cycloeudesmane (135) were described.
Among the 21 new/rare carbon skeletons, only single examples
were reported for 11 of them, namely, cyclococane (214),
calenzanane (215), friedoperforane (230), Güimarane (237),
rearranged cycloperforane (238), ring-contracted chamigrane
(239), spirolaurane (240), kylinane (241), cedrane (265),
friedooppositane (266), and aristolan-1α-bromo-9β,10β-epox-
ide (267) (Figure 21).
In addition to the sesquiterpenes with 10 known and 21
new/rare diﬀerent carbon skeletons discussed above, sesqui-
terpene derivatives with seven other skeletons (oplopane, 4,15-
cycloeudesmane, isocycloeudesmane, guaiane, aromadendrane,
poitane, and germacrane), were also reported from the
Rhodomelaceae (Figure 22). However, no halogenated
examples of these skeletons were reported to date. Such
nonhalogenated examples are beyond of the scope of this
review, but interested readers might refer to an excellent review
of this area by Erickson.24
4.3. Halogenated Diterpenes
Compared to the high number and great diversity of
sesquiterpenes already discussed above, and the nonterpenoid
Figure 20. Ten known sesquiterpenoid skeletons with halogenated representatives characterized from Rhodomelaceae.
Figure 21. Twenty new or rare sesquiterpenoid skeletons with halogenated representatives characterized from Rhodomelaceae.
Chart 1. Distribution of the 275 Halogenated Sesquiterpenes
of Rhodomelaceae Origin by Structural Classa
aBIS, bisabolane; BRA, brasilane; CHA, chamigrane; CUP, cuparane;
EUD, eudesmane; LAU, laurane; SNY, snyderane; NRS, new/rare
skeletonal sesquiterpenes; MIS, miscellaneous sesquitperpenes.
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C15-acetogenins that will be discussed later, the list of
Rhodomelaceae-derived diterpenes is relatively short. However,
several diﬀerent diterpene structural types, including members
of the irieane, labdane, and parguerane classes, are present in
species of the family, and were reported mainly from the genus
Laurencia. To date, at least 71 halogenated diterpenoids were
identiﬁed from the Rhodomelaceae.
4.3.1. Irieane Diterpenes. Diterpenes of the irieane class
contain a new tricyclic carbon skeleton consisting of a
cyclohexylmethyl unit coupled with an octahydroindene
system. The ﬁrst examples of this class, irieol A (276) and
iriediol (277) (Figure 23 and Supporting Information Table
S8), were identiﬁed from an undescribed Laurencia species
collected at Puerto Peñasco, Mexico in 1975 by Fenical and co-
workers, and their structures were determined by spectral and
X-ray crystallographic analysis.189 This species was later
assigned the name L. irieii based upon pioneering research in
Laurencia chemistry of Professor Toshi Irie at Hokkaidao
University.190 To date, a total of 14 diterpenes of the irieane
class corresponding to compounds 276−289 (Figure 23 and
Supporting Information Table S8),189−194 with irieol A (276)
being regarded as the archetypal compound of this class, were
isolated from three species of the genus Laurencia (L.
irieii,189,190 L. pinnata,191 and L. decumbens),192,193 with L. irieii
being the major producer (276−284).189,190 Without ex-
ception, irieane diterpenes are all dibrominated at C1 and C14
and each Br-substituent possesses the α-conﬁguration (Figure
23). In addition, compounds of this class generally possess a
free 4α-OH, with the only exceptions being pinnaterpene C
(287),191 11-O-deacetylpinnaterpene C (288),192,193 and 10-
acetoxyangasiol (289),194 which contained 4,18-epoxy and 18-
hemiacetal functionalities (287 and 288) or 4,18-lactone unit
(289) in their structures. Another feature of these molecules is
C11-oxygenation, but for 277 and 278 each contain a C10-
double bond.189,190
4.3.2. Labdane Diterpenes. Concinndiol (290),195 a
labdane diterpene identiﬁed from L. concinna, was the second
example of a bromoditerpene that found to occur naturally
(The ﬁrst was aplysin-20 from the sea hare Aplysia kurodai,196
which consumes red algae, especially Laurencia species, and
thus the true source of aplysin-20 appears likely to be a
Laurencia species). A total of twelve halogenated labdane
diterpenes (290−301, Figure 24 and Supporting Information
Table S9) were isolated from members of the family
Rhodomelaceae.195,197−205 Without exception, each of them is
brominated at C3, with one compound, 300,
205 containing an
additional Cl-substitution at C15. Compounds of this class
generally have OH groups at C8, C9, or C13. While
(−)-paniculatol (299) possesses an unusual tetrahydropyran
unit,204 compounds 300 and 301 respectively contain oxepane
and oxocane moieties previously unprecedented in this type of
metabolites.205 In the original report of isoconcinndiol (291),
the C8 conﬁguration was incorrectly assigned and the C13
conﬁguration was undetermined,197 and these were clariﬁed in
a latter report by synthesis.198 As indicated in Supporting
Information Table S9, at least seven species of the genera
Chondria and Laurencia were found to produce halogenated
labdane diterpenes, with L. pinnata being the most abundant
source of this compound type.
4.3.3. Parguerane, Isoparguerane, Neoparguerane,
and Pimarane Diterpenes. The parguerane skeleton, a new
carbocyclic framework comprising a 3,18-cyclopimarane
system, was named by Schmitz and co-workers in 1981 when
parguerol and a series of related derivatives were ﬁrst isolated
from the sea hare Aplysia dactylomela collected near La
Parguera, Puerto Rico.206,207 As mentioned above, sea hares
are known to consume large quantities of red algae, so it was
not surprising that several diterpenes of this type were
subsequently isolated and reported from marine red algae,
including Laurencia species. In 1982, the ﬁrst example of a
brominated parguerane diterpene of algal origin, 15-bromo-
2,16-diacetoxy-7-hydroxy-9(11)-parguerene (302, Figure 25
and Supporting Information Table S10), was obtained from
L. obtusa that was collected from the English Channel at
Kimmeridge Bay, Dorset.208 Subsequently, 12 additional
halogenated parguerane derivatives (303−314, Figure 25 and
Supporting Information Table S10) were isolated from L.
Figure 22. Seven sesquiterpenoid skeletons found among Rhodome-
laceae metabolites for which halogenated representatives have not
been reported.
Figure 23. Irieane diterpenes (276−289).
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f iliformis, L. nipponica, and L. obtusa collected from Australian,
Russian, and Japanese waters,209−212 respectively, with L.
f iliformis being the most proliﬁc producer (307−312).211
Apart from the parguerane diterpenes, two related isomeric
bromoditerpenes, deacetylisoparguerol (315)210 and 2α-
acetoxy-15S-bromo-7α,16-dihydroxy-3β-palmitoyloxy-4(19),9-
(11)-neopargueradiene (316),210,213 which possess isoparguer-
ane and neoparguerane skeletons, respectively, were identiﬁed
from L. obtusa by Suzuki’s group in 1990. From a biogenetic
point of view, the isoparguerane skeleton appears to be derived
from rearrangement of cyclopropane and C19 units in the
parguerane framework, while the neoparguerane skeleton is
likely generated through cleavage of the cyclopropane ring
between C3 and C4 of the parguerane skeleton. In addition to
parguerane, isoparguerane, and neoparguerane diterpenes, two
new brominated pimarane diterpenes, 3,15-dibromo-9(11)-
isopimarene-7,16-diol (317), and 3,15-dibromo-9(11)-isopi-
marene-7,12,16-triol (318) were also characterized from L.
perforata collected at the Canary Islands.214
The diterpenes discussed in this section are all brominated
and the Br-substitution is restricted to C15, while C16 is
oxygenated. Another feature of these derivatives is the presence
of a double bond at C9(11), with only one exception, compound
314, which has this functional group at C7.
212
4.3.4. Miscellaneous Diterpenes with New or Rarely
Reported Skeletons. In addition to the halogenated
diterpenes discussed above, 28 diterpenes (319−346, Figures
26 and 27 and Supporting Information Table S11) with 14 new
or rarely reported carbon skeletons were also discovered from
species of the family Rhodomelaceae.67,145,149,192,193,214−229
These diterpenes, as summarized in Supporting Information
Table S11, possess a diverse array of ring systems including
mono- (319−324), bis- (325−334), and tricarbocyclic systems
(335−346), with some of them containing spiro- (339−341)
or cyclic ether/epoxide (320, 323, 324, 329, 338, and 339)
systems. All of these diterpenes are brominated, with two of
them, dactylomelol (320)215 and laurencianol (324),217 also
containing a chlorine atom. Some of these diterpenes
possessing a rigid cis-1,2-bromohydrin (322, 323, 325−331,
and 342−346) or chlorohydrin (324) unit. L. microcladia216,219
and L. obtusa217,218,220,221 are the two most proliﬁc producers of
haloditerpenes having new or rarely reported skeletons
(Supporting Information Table S11).
4.4. Halogenated Triterpenes/Polyethers
Rhodomelaceae-derived triterpenes also comprise a relatively
small group of metabolites compared to the number of
sesquiterpenes and nonterpenoid C15-acetogenins obtained
from this family. All of the halogenated triterpenes found to
Figure 24. Labdane diterpenes (290−301).
Figure 25. Parguerane (302−314), isoparguerane (315), neo-
parguerane (316), and pimarane (317 and 318) diterpenes.
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date from the family are noncarbocyclic polyethers that are
biogenetically derived from squalene. An excellent review
dealing with the structures, biogenetic considerations, and
biological activities of both halogenated and nonhalogenated
polyethers from red algae and sponges appeared in 2000.230 On
the basis of their structural characteristics, the halogenated
triterpenes of Rhodomelaceae origin can be divided into three
diﬀerent classes including those with a 2,7-dioxabicyclo[4.4.0]-
decane skeleton, those with a 2,8-dioxabicyclo[5.4.0]undecane
skeleton, and one having a distinctive C2 symmetry element.
4 . 4 . 1 . T r i t e r p e n e s P o s s e s s i n g a 2 , 7 -
Dioxabicyclo[4.4.0]decane Skeleton. The 2,7-
dioxabicyclo[4.4.0]decane moiety is a typical feature in most
of the triterpenes reported from the Rhodomelaceae. A total of
33 ha logenated tr i terpenes that possess a 2 ,7-
dioxabicyclo[4.4.0]decane unit are known from this family
(347−379, Figure 28 and Supporting Information Table
S12).127,231−248 This unit is generally connected to an oxane
moiety by a single bond in the left side, while in the right side it
connected to a side chain diﬀering at C15 through C24 either in
the conﬁguration of the chiral centers (e.g., thyrsiferol
347231−233 and venustatriol 348),233 in the degree of oxidation
(e.g., thyrsiferol 347 and dehydrothyrsiferol 350),127 or in the
number and size of cyclic ether ring(s) (e.g., magireol A 353,235
thyrsiferol 347, callicladol 356,236 and isodehydrothyrsiferol
365).241 Among these, isodehydrothyrsiferol (365) is the only
example containing an oxane unit in the right side chain,241
while thyrsenols A and B (376 and 377)248 and 15-
dehydroxythyrsenol A (378)246 each possesses an unusual
enol-ether moiety. In addition, clavidol (372),242 prethyrsenol
A (373), 13-hydroxyprethyrsenol A (374),246 and 14-keto-
dehydrothyrsiferol (375)247 are the only examples in this series
without a 10,14-cyclic ether ring. Without exception, each
compound in this category is C3 brominated with β-
conﬁguration implying the strict biogenetic bromination
pathway for this kind of compounds. The archetypal compound
of this class is thyrsiferol (347), which was the ﬁrst squalene-
derived halogenated triterpenes to be described, and was
isolated from L. thyrsifera collected at Seal Reef, Kaikoura, New
Zealand.231 The structure of 347 was determined on the basis
of spectroscopic methods, as well as X-ray crystallographic
analysis of its 18-acetate,231 and the 1H and 13C NMR data for
this compound was fully assigned in a subsequent report.232
Compounds of this class occur mainly in species of L.
obtusa234,235 and L. viridis,237−242,246−248 as well as in L.
calliclada,236 L. mariannensis,243 L. pinnatif ida,127 L. thyrsifera,231
and L. venusta233 (Supporting Information Table S12). It
should be noted that 21α-hydroxythyrsiferol (367) and
laurenmariannol (368) were reported as new compounds
from L. mariannensis in 2008.243 However, the spectroscopic
Figure 26. Miscellaneous diterpenes with new or rarely reported skeletons (319−334).
Figure 27. Miscellaneous diterpenes with new or rarely reported
skeletons (335−346).
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data of these two compounds were very similar to those of
aplysiols A and B, which were isolated from the sea hare Aplysia
dactylomela in 2007.244 Sea hare are known to feed upon
Laurencia species, and it thus seems likely that the true origin of
these compounds is dietary algae. Recently, the relative
conﬁguration of laurenmariannol (aplysiol B, 368) was revised
with the aid of a 1D gradient selective NOESY experiment.245
4 . 4 . 2 . T r i t e r p e n e s P o s s e s s i n g a 2 , 8 -
Dioxabicyclo[5.4.0]undecane Skeleton. Compounds
380−388 fall into a class of halogenated triterpenes/polyethers
having a 2,8-dioxabicyclo[5.4.0]undecane unit (Figure 29 and
Supporting Information Table S12).240,249−253 Seven of them,
380−386,240,249 feature an oxepane ring fused to the 2,8-
dioxabicyclo[5.4.0]undecane unit thereby aﬀording a 7/7/6-
ring system, which further connects via single bonds either to
an oxolane ring (380)240 or to an oxepane ring (381−386).249
In contrast, two other triterpenes, enshuol (387)250,251 and
aurilol (388),252,253 possess a 2,8-dioxabicyclo[5.4.0]undecane
unit connected via a single bond to three and two isolated
oxolane rings, respectively. These triterpenes are all brominated
at C3, but not for armatol A (381, with C22 bromination), and
usually possess β-conﬁguration (except for 382 and 383).
Armatols B−F (382−386)249 have additional bromine
substitution at C22 with β-conﬁguration. Compounds of this
class of triterpenes were found in samples of Chondria
armata,249 Laurencia omaezakiana,250,251 and L. viridis,240 as
well as in the sea hare Dolabella auricularia,252,253 which is
known to feed on marine algae like Laurencia species.
4.4.3. Triterpenes Possessing Symmetric Element(s).
The chlorinated bromotriterpene intricatetraol (389, Figure 29
and Table S12) was identiﬁed from Laurencia intricata collected
from three diﬀerent sites near Hokkaido, Japan.254 This
compound is the only example of a halogenated triterpene
with a C2 symmetrical structure and was the ﬁrst example of a
chlorine-containing triterpene found from a species of the
family Rhodomelaceae.
4.5. Halogenated Nonterpenoid C15-Acetogenins (ACGs)
The C15-acetogenins (ACGs) are a large group of halogenated
organic molecules that are commonly found in species of the
family Rhodomelaceae. It is generally accepted that these ACGs
arise from a common C15 precursor, which is in all probability
derived from a C16 fatty acid. In addition to a few linear ACGs,
most of these ACG derivatives are characterized as cyclic ether
metabolites varying in ring sizes and usually contain a
conjugated enyne or bromoallene terminus. Since the isolation
of laurencin, the ﬁrst Rhodomelaceous ACG derivative, from
Laurencia glandulifera in 1965,255 reports of such molecules
have rapidly grown in number. On the basis of data in hand,
180 Rhodomelaceae-derived halogenated ACGs (390−569)
were described to date. In the discussion below, these ACGs are
grouped into linear and cyclic ether classes, with the latter
Figure 28. Triterpenes/polyethers of 2,7-dioxabicyclo[4,4,0]decane class (347−371) and the related congeners (372−379).
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further divided according to the size of the largest ether ring
present.
4.5.1. Linear ACGs. The ﬁrst example of a halogenated
linear ACG, 6-acetoxy-7-chloro-3Z,9Z,12Z-pentadecatrien-1-
yne (390), was isolated from Laurencia pinnatif ida in
1982.256 A total of eleven members of this metabolite class
were identiﬁed so far, with eight (390−397)256,257 from L.
pinnatif ida, one (398)258 from L. glandulifera, and very recently,
two (399 and 400)259 from a newly described species, L.
marilzae (Figure 30 and Supporting Information Table S13).
These ACGs are all oxygenated at C6 and chlorinated at C7,
with only one exception, 398, which is chlorinated at C6 and
oxygenated at C7. Each of these ACGs contains a cis- or trans-
enyne terminal moiety and one or two isolated double bond(s),
and all these isolated double bonds possess Z-geometry, except
for the case of 398.258
4.5.2. ACGs of the Five-Membered Cyclic Ether Class
(Tetrahydrofuran ACGs, THF ACGs). Sixteen halogenated
compounds (401−416, Figure 31 and Supporting Information
Table S13) fall into the class of ﬁve-membered cyclic ether
ACGs (or tetrahydrofuran ACGs, THF ACGs) of Rhodome-
laceae origin.72,116,258,260−264 They all possess an ethyl group as
one terminus, while four diﬀerent units may be present as the
other terminus: one has a bromopropargylic unit (412),263 two
have bromoallenic groups (413263 and 414),116 and the other
thirteen have a cis- or trans-enyne moiety. Compounds of this
class are generally brominated, with three of them chlorinated
(407−409)258 and four bromochlorinated (410, 411,258 415,72
and 416).264 The ﬁrst halogenated THF ACG to be reported
was laureepoxide (401), which was isolated from L. nipponica
collected from Hokkaido, Japan.260 This compound is also the
ﬁrst example of a brominated ACG derivative containing both
oxolane and oxirane rings. The THF ACGs occur mainly in L.
glandulifera,258 L. nipponica,260−262 and L. obtusa.72,263
4.5.3. ACGs of the Bis-Tetrahydrofuran Class (Bis-THF
ACGs). Seven compounds (417−423), including ﬁve deriva-
tives possessing a 2,2′-bis-tetrahydrofuran substructure (417−
421)107,265−270 and two having isolated oxolane rings (422271
and 423),272 comprise the class of halogenated bis-THF ACGs
(Figure 32 and Table S13), which were found among ﬁve algal
species (L. decumbens,269,270 L. elata,267,268 L. majuscu-
la,107,265,268 L. nipponica,266 and L. obtusa).271,272 Each of
these ACGs also has an ethyl group as one terminus. Six of
them possess cis- or trans-enyne moieties at the other terminus,
while the seventh, 423,272 has a bromoallenic unit. All of these
bis-THF-ACGs are brominated and compounds 418,266
420,107,268 and 421269,270 also contain a Cl-atom. Compound
423 is the only tetrabrominated derivative among all of the
ACGs isolated from Rhodomelacese.272 Among the bis-THF
ACGs, the presence of two 2,2′-bis-tetrahydrofuran derivatives,
419 (elatenyne) and 420, are perhaps most noteworthy. These
two compounds were originally characterized as 2,7-
dioxabicyclo[4.4.0]decane metabolites of L. elata267 and L.
majuscula,107 respectively. However, their structures were later
revised to 2,2′-bis-tetrahydrofuran derivatives by total syn-
thesis.268 Similar revision was made to the structure of
laurendecumenyne B (421),270 which was originally isolated
from L. decumbens and its structure was elucidated solely by
NMR comparison with that of originally assigned for 419.269
ACGs hav ing 2 ,2 ′ -b i s - t e t r ahydro fur an and 2 ,7 -
dioxabicyclo[4.4.0]decane units possess the same carbon and
Figure 29. Triterpenes/polyethers of 2,8-dioxabicyclo[5,4,0]undecane
class (380−388) and one possessing symmetric element (389).
Figure 30. Linear acetogenins (390−400).
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proton connectivity, making unambiguous structure assignment
solely by NMR analysis challenging.268 Therefore, other
evidence, such as chemical transformation, total synthesis,
computation modeling, or X-ray crystallographic data are
particularly important for structure conﬁrmation in these cases.
4.5.4. ACGs of the 2,6-Dioxabicyclo[3.3.0]octane
Class. Thirteen ACGs of the 2,6-dioxabicyclo[3.3.0]octane
class, which contain two ﬁve-membered ether rings derived
either from C4−C7 and C6−C9 etheriﬁcation (424−
433)67,203,273−280 or from C7−C10 and C9−C12 etheriﬁcation
(434−436),281,282 were isolated from the Rhodomelaceae
(Figure 33 and Supporting Information Table S13), with
obtusin (424), which was isolated and reported by Howard and
co-workers from a Mediterranean variety of L. obtusa in 1979,
was the ﬁrst example of this class.273 The structure of obtusin
(424) was determined by analysis of spectral data as well as by
X-ray crystallographic studies of its 3-OH derivative, obtusinol,
which was obtained by treatment of obtusin (424) with an
excess of silver acetate in glacial acetic acid, followed by
saponiﬁcation of the resulting acetate with methanolic KOH.273
This compound as well as two other congeners, neoobtusin
(425)274 and chinzallene (426),203 contain an additional ﬁve-
membered cyclic ether ring derived from C9−C12 etheriﬁcation,
and thus forming a unique and unprecedented bicyclic ketal
motif. All halogenated ACGs of the 2,6-dioxabicyclo[3.3.0]-
octane class are brominated, with one compound, 430, also
containing a Cl-atom as part of a chlorohydrin moiety in the
structure.276 The bromoallenic unit is the most frequently
occurring terminus among this group of ACGs, although
bromopropargylic- (424273 and 425274) and cis-enyne (434−
436)281 termini are also present in some of these compounds.
Figure 31. ACGs of the tetrahydrofuran class (401−416).
Figure 32. ACGs of the 2,2′-bis-tetrahydrofuran class (417−423).
Figure 33. ACGs of the 2,6-dioxabicyclo[3.3.0]octane class (424−436).
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ACG derivatives of this 2,6-dioxabicyclo[3.3.0]octane class are
mainly found from species of L. intricata275−278 and L.
obtusa,273,274 but also occur in L. mariannensis,67 L. nidif ica,282
L. nipponica,279 L. okamurai,280 and some undescribed
Laurencia species.281
4.5.5. ACGs of the Six-Membered Cyclic Ether Class
(Tetrahydropyran ACGs, THP ACGs). Surprisingly, only two
tetrahydropyran (THP) ACG derivatives were identiﬁed from
the Rhodomelaceae to date. Scanlonenyne (437)283 was
isolated from L. obtusa that was collected at Scanlon Islands,
Ireland, and bisezakyne B (438)264 was obtained from an
undescribed Laurencia species collected at Bisezaki, Okinawa,
Japan (Figure 34 and Supporting Information Table S13).
Compound 437 is brominated and possesses a cis-enyne
terminus, while 438 is bromochlorinated and has a trans-enyne
terminus. The former represents the ﬁrst halogenated C15-
acetogenin with a ketone functionality at the C7 position from a
Laurencia species. This compound was very unstable and a large
amount of the sample decomposed despite refrigerated
storage.283
4.5.6. ACGs of the 2,7-Dioxabicyclo[4.3.0]nonane
Class. Thus far, only three ACGs containing a 2,7-
dioxabicyclo[4.3.0]nonane skeleton, japonenynes A−C (439−
441, Figure 35 and Supporting Information Table S13), all
brominated at C6 and C12 and having either a cis- or a trans-
enyne terminus, were described.284 These compounds were
isolated from a Japanese L. japonensis and their structures were
deduced from spectral evidence. They were observed to be very
unstable and decomposed even when stored at −18 °C for a
few days. Japonenyne C (441) may be an artifact formed
during the extraction process.284
4.5.7. ACGs of the Seven-Membered Cyclic Ether
Class. 4.5.7.1. Seven-Membered Monocyclic Ether (Oxepane)
ACGs. ACGs of the monocyclic oxepane class share common a
cyclic ether ring that is formed by C7−C12 etheriﬁcation. Five
compounds including one brominated (442)285 and four
bromochlorinated derivatives (443−446)286,287 fall into this
class, with the former having a bromoallenic terminus and the
latter possessing cis- or trans-enyne termini (Figure 36 and
Supporting Information Table S13). The C9 and C10 positions
in these ACGs are usually functionalized, either as part of a
double bond (442,285 443,286 and 446),287 an epoxy unit
(444),286 or a chlorohydrin moiety (445),286 while the C6
position is either oxygenated (442)285 or chlorinated (443−
446).286,287 Compounds of this class reported so far are present
in species of L. microcladia,286 L. nipponica,285 and L. pinnata287
collected either from Mediterranean or from Japanese waters.
4.5.7.2. Seven-Membered Cyclic Ether ACGs with Addi-
tional 6,9-Epoxide Ring. Four oxepane ACGs coupled with a
6,9-epoxide ring including isoprelaurefucin (447),288 (3Z)-
isoprelaurefucin (448),289 and (3Z)-neoisoprelaurefucin
(449)290 from L. nipponica, and (3E)-neoisoprelaurefucin
(450) from L. obtusa,40 were reported from members of the
Rhodomelaceae (Figure 37 and Supporting Information Table
S13). All these compounds are dibrominated at C10 and C13
and have the same planar structure, diﬀering only in their
stereochemistry. Each compound has 1-bromopropanyl- and
enyne-termini, in the left and right sides, respectively.
4.5.8. ACGs of the Eight-Membered Cyclic Ether Class.
The ﬁrst eight-membered cyclic ether ACG derivative,
laurencin (451, Figure 38), was identiﬁed from a Hokkaido
specimen of L. glandulifera in 1965,255 and its isolation and
structure determination were reported in detail in 1968.291 The
structure was determined by spectroscopic and chemical
methods and was conﬁrmed by X-ray crystallographic
analysis.292,293 To date, a total of 75 halogenated derivatives
of eight-membered cyclic ether ACGs (451−525, Figures 38−
Figure 34. ACGs of the six-membered cyclic ether class (437 and
438).
Figure 35. ACGs of the 2,7-dioxabicyclo[4.3.0]nonane class (439−
441).
Figure 36. ACGs of the seven-membered cyclic ether class (442−
446).
Figure 37. ACGs of the seven-membered cyclic ether class (447−
450).
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42 and Supporting Information Table S13) were described
from members of the family Rhodomelaceae, making it the
most abundant class of halogenated organic molecules found in
this taxonomic group. Based on the ring closure system in the
structures, this class of ACGs can be further divided into seven
subclasses including those with 7,13-epoxy (451−464, Figure
38),255,287,291−299 6,9:7,13-bisepoxy (465−471, Figure
39),108,178,299−302 6,10:7,13-bisepoxy (472269 and 473,303
F i g u r e 3 9 ) , 6 , 1 2 - e p o x y ( 4 7 4− 5 0 9 , F i g u r e
40),124,175,225,256,259,304−323 4,7:6,12-bisepoxy (510−518, Fig-
ure 41),269,271,276,285,324−328 4,10:9,13-bisepoxy (519−521,
Figure 42),329 and 4,14:6,12-bisepoxy (522−525, Figure
42)330 frameworks.
All members of the ﬁrst three subclasses (451−473, Figures
38 and 39) feature an ethyl unit at one terminus and a cis- or
trans-enyne moiety at the other. As for the fourth and ﬁfth
subclasses (474−518, Figures 40 and 41), a bromopropyl unit
frequently occurs at one terminus, with the other consisting of
either a cis- or trans-enyne moiety for the fourth subclass (474−
506, Figure 40) or a bromoallenic or bromopropargylic units
for the ﬁfth subclass (510−518, Figure 41). Microcladallenes
A−C (519−521, Figure 42) identiﬁed from L. microcladia (oﬀ
the French coast at Cape Ferrat)329 and marilzabicycloallenes
A−D (522−525, Figure 42) isolated from a newly described
species L. marilzae (Canary Islands, Spain),330 are the only
representatives of the sixth and seventh subclasses of ACG
derivatives to be reported so far. Each of these compounds
contains a bromoallenic unit at one terminus and an ethyl-
(519 and 521), or oleﬁnic (520), or methyl (522−525) unit at
the other.
The C9 and C10 positions in the eight-membered cyclic ether
ACGs are usually functionalized as a double bond (451−444,
462, 463, 474, 476−480, 485, 487, 491, 494−497, 499, 502−
505, 507−509, 510−512, and 517), a diol (455, 456, and
518), an epoxy (464, 475, 488, 500, and 501), or a halohydrin
unit (457, 461, 486, 489, 490, 492, 493, 506, and 513−515),
while the C6 position in the ﬁrst subclass is either chlorinated
(452−461) or oxygenated (451, 462−464). Eight-membered
cyclic ether ACGs have most often been found in L.
glandulifera,255,291,297 L. intricata,276,294,295,298 L. marilzae,259,330
L. nipponica,285,300,301,303,308−313,324,325 and L. obtu-
sa.271,314−319,326
4.5.9. ACGs of the Nine- and Ten-Membered Cyclic
Ether Classes. The ﬁrst ACG of the nine-membered cyclic
ether class, obtusenyne (526, Figure 43 and Supporting
Information Table S13), was isolated independently by two
research groups from L. obtusa with samples collected from
Positano, Italy299 and from Gökceada in the Aegean Sea.331 So
far, 10 nine-membered cyclic ether ACG derivatives including
those containing 6,13-epoxy (526−528),257,299,331,332 4,7:6,13-
bisepoxy (529−534),108,116,269,327,333−335 and 5,12-epoxy
(535)108 ring systems, were reported from the Rhodomelaceae.
These ACGs are all brominated, usually at C12, with three
members, the 6,13-epoxy ACGs 526−528, having additional
chlorine substitution at C7.
257,299,331,332 Each of these ACGs
(526−534) features an ethyl unit at one terminus, except for
the 5,12-epoxy ACG derivative 535, which has a bromopropyl
unit.108 As for the other terminus, the 6,13-epoxy (526−528)
and 5,12-epoxy (535) ACGs possess either a cis- or trans-enyne
group, while the 4,7:6,13-bisepoxy ACGs (529−534) possess a
bromoallenic moiety. The C9 and C10 positions of these ACGs
are also functionalized either as a double bond (526−531 and
535) or a diol (534) or are oxygenated and brominated (532
and 533). It is worth mentioning that a recently reported
asymmetric total synthesis of itomanallene A indicated that the
initially proposed α,α′-cis-tetrahydrofuran moiety should be
corrected to α,α′-trans-conﬁguration (531),336 which is a
common feature for ACGs of 4,7:6,13-bisepoxy series (529−
534). ACGs of the nine-membered cyclic ether class were
found in L. decumbens,269 L. implicata,108,327 L. intricata,116 L.
nipponica,333,334 L. obtusa,299,331 L. okamurai,334,335 and L.
pinnatif ida.257,332
Thus far only one ten-membered cyclic ether ACG,
compound 536 (Figure 44 and Supporting Information Table
S13), was described from the Rhodomelaceae.108 This
brominated compound was isolated from L. implicata collected
Figure 38. ACGs of the eight-membered cyclic ether class (451−464).
Figure 39. ACGs of the eight-membered cyclic ether class (465−473).
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from Florence Bay, Magnetic Island, and possesses normal
ethyl and cis-enyne units as termini. The absolute conﬁg-
urations of the stereocenters in 536 were not deﬁned.
4.5.10. ACGs of the Twelve-Membered Cyclic Ether
Class. The ﬁrst twelve-membered cyclic ether ACG to be
described was obtusallene I (537) that was isolated from L.
obtusa collected at Gökceada in the Aegean Sea.337 To date, a
total of 14 ACG metabolites of this class (537−550, Figure 45
and Supporting Information Table S13) were obtained from
Rhodomelaceae, with 11 of them were isolated from L. obtusa
(537−541 and 545−550),337−343 and three of them were
recently identiﬁed from a newly described species, L.
marilzae.259 These ACGs feature a 4,14-epoxy linkage to
form the twelve-membered cyclic ether ring and each of them
have methyl and bromoallenic termini. In addition to the
twelve-membered ring, these ACG derivatives usually contain
an additional O-bridged ﬁve- or six-membered ring in the
structures, with two of them, obtusallenes V and VI (545 and
546), containing two ﬁve-membered cyclic ether rings that
derived from C6−C9 and C9−C12 etheriﬁcation, thereby
forming a unique and unprecedented spiro-ketal motif in
each case.341,342 The members of this group are all brominated
and some are bromochlorinated (537−539337−339 and 541−
547).259,340−342 The placement of the bromine atom at C7 and
chlorine atom at C13 for obtusallenes V−VII (545−547) was
originally assigned by NMR spectroscopic analysis.341 However,
the results from GIAO-based density functional prediction
revealed that the positions of the halogen atoms at C7 and C13
in these compounds should be reversed.342 These results again
indicated the challenge for the structure assignment by NMR
spectral analysis of bromochlorinated metabolites. In addition,
the assignment of relative conﬁgurations for the macrocyclic
ether ACGs such as obtusallene V (545) is also troublesome
because of the superimposition of the 1H NMR signals and
conformational ﬂexibility in the functionalized portion of the
macrocycle.341 Collecting 1H NMR spectra in diﬀerent NMR
Figure 40. ACGs of the eight-membered cyclic ether class (474−509).
Figure 41. ACGs of the eight-membered cyclic ether class (510−518).
Figure 42. ACGs of the eight-membered cyclic ether class (519−525).
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solvents might be a solution of the problem of signal
superimposition.341
4.5.11. ACGs of the Maneonene and Isomaneonene
Classes. Two other sets of ACG derivatives from the
Rhodomelaceae, 551−55996,344−349 and 560−562 (Figures
46 and 47 and Supporting Information Table S13),345,346,349
were named as maneonene and isomaneonene classes,
respectively. These compounds diﬀer from the other ACGs
discussed above in that the carbon chain cyclized back on itself
to form a carbocyclic ring in maneonenes (C6−C11 bond, 551−
559) and biscarbocyclic rings in isomaneonenes (C5−C13 and
C6−C11 bonds, 560−562). Each of the maneonene and
isomaneonene ACG derivatives features terminal ethyl and
cis- or trans-enyne units. All maneonene ACGs (551−559) are
bromochlorinated, with chlorine at C5 and bromine at C13,
while the isomaneonenes (560−562) are all dibrominated at
C12 and C13. The ﬁrst examples of maneonene derivatives were
cis-maneonenes A (551) and B (552), and trans-maneonene B
(553) (Figure 46), which were isolated from a green variety of
L. nidif ica collected oﬀ the south coast of Oahu, Hawaii.344,345
Figure 43. ACGs of the nine-membered cyclic ether class (526−535).
Figure 44. ACG of the ten-membered cyclic ether class (536).
Figure 45. ACGs of the twelve-membered cyclic ether class (537−550).
Figure 46. ACGs of the maneonene class (551−559).
Figure 47. ACGs of the isomaneonene class (560−562).
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Recently, (12E)-cis-maneonene E (555) was isolated from two
Laurencia species, L. papillosa347 and L. obtusa,348 and was
reported twice by the same group in 2011.347,348 Confusingly, a
diﬀerent conﬁguration at C6 was described in the reports,
although the assignment in the latter report seems more
reasonable.348 As for the isomaneonene class, the only three
ACGs of this type reported so far are isomaneonenes A (560)
and B (561) from a Hawaiian collection of L. nidif ica345,346 and
the C5-isomer of 560, lembyne B (562), from an unidentiﬁed
Malaysian Laurencia species (Figure 47).349
4.5.12. Branched ACGs. All of the ACG derivatives
discussed above incorporate a linear C15 chain, with the chain
either modiﬁed or folded to form cyclic ethers or carbocycles,
and, most terminate with an enyne or bromoallene function. In
1991, however, the ﬁrst ACGs found to contain a branched C15
chain, rogiolenynes A−C (563−565, Figure 48 and Supporting
Information Table S13), were reported from the alga L.
microcladia and the sponge Spongia zimocca.350 These two
organisms occur in the same small area in the Mediterranean
oﬀ the Torrent Il Rogiolo, south of Livorno. It is suggested that
rogiolenynes B (564) and C (565) might be derived by
transferring rogiolenyne A (563) from the alga L. microcladia to
the sponge S. zimocca where it undergoes epoxide opening by
Cl− to give 564, followed by acetylation to give 565.350 Another
study of the same algal sample aﬀorded rogiolenyne D (566), a
novel branched ACG that was hypothesized to be the parent
compound in this series.351 All of these branched ACGs have
terminal ethyl and cis-enyne units, and all are bromochlori-
nated, with a bromine atom at C15 and a chlorine atom at C6.
Two of them, rogiolenynes B (564) and C (565), have
additional chlorine substitution at C9.
350 The structures of these
compounds were established by extensive spectral analysis as
well as by chemical transformation, and the absolute
conﬁguration was assigned via the Mosher’s NMR method
applied to the MTPA esters of rogiolenyne B (564).350
4.5.13. Miscellaneous ACGs. Two novel ACGs,
(3E,6R*,7R*,9R*,10S*)-6,9:7,10-bisepoxy-13-chloro-12-hy-
d r o x y p e n t a d e c a - 3 , 1 4 - d i e n - 1 - y n e ( 5 6 7 ) a n d
(3E,6R*,7R*,9R*,10S*,13E)-6,9:7,10-bisepoxy-15-chloro-12-
hydroxypentadeca-3,13-dien-1-yne (568), both possessing the
rare 2,5-dioxabicyclo[2,2,1]heptane ring system (Figure 49 and
Supporting Information Table S13), were identiﬁed from L.
majuscula collected from Holmes Reef, Queensland, Austral-
ia.107 Another novel ACG derivative (569) containing isolated
tetrahydrofuran and tetrahydro-2H-pyran rings was obtained
from L. obtusa collected oﬀ the Island of La Graciosa of Canary
Island.271
4.6. Halogenated Indoles
Twenty-seven haloindoles (all brominated) were described so
far from the family Rhodomelaceae (570−596, Figure 50 and
Supporting Information Table S14). These compounds can be
classiﬁed into three subclasses: the monoindoles (570−
580 ) , 3 5 2− 3 5 6 t he N -me thy lmono indo l e s (581−
587) ,185 , 192 , 354 , 355 , 357 and the bis indoles (588−
596).353,356−358 All of these compounds contain at least two
bromine atoms. Except for three N-methylmonoindoles 582,354
585,357 and 587,192 these indoles generally possess a bromine
substituent at C6. In addition to the bromine substitutions,
fourteen of them contain sulfur (570, 571,352 574,353 578−
580,356 and 589−596).353,356,358 All of the brominated indoles
reported to date were found in the species L. brongniar-
tii352−354,356,358 L. decumbens,192 and L. similis (Supporting
Information Table S14).355,357
4.7. Halogenated Phenols/Aromatics
The number of halogenated phenols/aromatic compounds
obtained from members of the Rhodomelaceae has grown
considerably in recent years. A total of 92 halophenols (597−
688, Figures 51−55 and Supporting Information Table S15)
were isolated and identiﬁed from these sources, with 66 of them
were described since 2000. On the basis of the number of
benzene rings in the molecules, these halophenols can be
divided into mono- (597−648,2,359−381 Figures 51 and 52), di-
(649−683,363,365−369,373,375,380−394 Figures 53 and 54), tri-
(684−687,363,368,386,395,396 Figure 55), and tetra-aryl classes
(688,397 Figure 55). All of these compounds are brominated or
polybrominated. Among these, 2,3-dibromobenzyl alcohol 4,5-
disulfate dipotassium salt (597, Figure 51), isolated from
Polysiphonia lanosa in 1966, was the ﬁrst aromatic metabolite
isolated from a natural source that contains bromine on
contiguous carbon atoms.359 The 2,3-dibromobenzyl moiety
appears the most commonly occurring structural unit in the
bromophenols of Rhodomelaceae origin, with 63 such
representatives having been identiﬁed so far (597, 600−603,
608−615, 617−621, 623, 624, 629−635, 637, 638, 642−646,
649−666, 669−671, 673−677, and 685−687, Figures 51−55
and Supporting Information Table S15). Most of them were
characterized from the species of the genera Rhodome-
la2,361−369,382−384 and Symphyocladia.370−374,380,390 Bromophe-
nols from the genus Symphyocladia usually contain an
additional bromine atom at C6, thereby forming a 2,3,6-
Figure 48. Branched ACGs (563−566).
Figure 49. Miscellaneous ACGs (567−569).
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tribromobenzyl moiety (629−635, 645, 646, 659−661, 666,
675, and 676).370−374,380,390 Other bromophenols isolated from
Rhodomelaceae including compounds 610 from R. confer-
voides365 and 646 from S. latiuscula380 containing unique
sulfoxide and methyl sulfone moieties, respectively, while
compounds 617−619 from R. confervoides appear to be the ﬁrst
examples of bromophenols coupled with an amino acid or
nucleoside unit through a C−N bond,367 and compound 623
represents the ﬁrst report of a bromophenol coupled with a γ-
ureidobutyrate unit.368
Compared to the large number of mono- and diaryl
bromophenols found from the Rhodomelaceae, only four
triaryl (684−687)363,368,386,395,396 and one tetra-aryl (urceola-
tin, 688)397 brominated aromatic compounds were reported to
date (Figure 55 and Supporting Information Table S15).
Among these, cyclotribromoveratrylene (684) is a unique
symmetrical trimer isolated from Halopytis pinastroides (Syn. H.
incurvus).395 Conformational studies of this compound revealed
that the bromine atoms force the nine-membered ring from the
crown conformation into a “ﬂexible boat” conformation.396
The genera Polysiphonia, Rhodomela, and Symphyocladia are
the most proliﬁc sources of bromophenols to date, with 15, 46,
and 15 such compounds, respectively, isolated and charac-
terized from species of these three genera, accounting for 76 of
the 92 bromophenols isolated from this algal family
(Supporting Information Table S15).
4.8. Other Halogenated Organic Molecules
Nine other halogenated organic molecules, 3,4-dibromo-5-
methylenecyclopent-3-ene-1,2-diol (689) from V. spiralis,398
poitediene (690) from L. poitei,399 (Z)-2-chloropentadec-2-enal
(691) from L. f lexilis,100 2-(tetrahydro-4-iodo-2-methyl-6-oxo-
2H-pyran-4-yl)ethyl stearate (692) from L. majuscula,400
adejens A and B (693 and 694) from L. viridis,247 and highly
brominated aromatic derivatives 695−697 from L. similis,385
were also characterized from members of the Rhodomelaceae
(Figure 56 and Supporting Information Table S16). Among
these, compound 690 is an unusual 15-carbon nonterpenoid
metabolite containing a previously unreported twelve-mem-
bered ring system with a 1,2-dibromoethylenyl group,399 while
compounds 691100 and 692400 contain unusual chloroenal and
iodolactone units, respectively. Recently, Blunt and co-workers
indicated that the structures for the highly brominated
derivatives 695−697 should be re-examined because of
inconsistencies in the published NMR data for these
compounds.401
4.9. Summary to the Occurrence of Halogenated Organic
Molecules
This review presents a total of 697 halogenated organic
molecules originating from members of the algal family
Rhodomelaceae. These compounds are generally classiﬁed
into sesquiterpene, diterpene, triterpene/polyether, acetogenin,
indole, and phenolic classes, with the majority (618, 89%)
Figure 50. Indole derivatives (570−596).
Figure 51. Monoaryl bromophenolic derivatives (597−622).
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being sesquiterpenes (275, 40%), acetogenins (180, 26%),
phenols/aromatics (92, 13%), or diterpenes (71, 10%) (Chart 2
and Supporting Information Tables S1−S16). The geographical
origins of all 697 compounds described in this review are
summarized in Chart 3, as well as in Supporting Information
Tables S1−S16. Although the sampling sites were not given in
some of the earliest references, thus making the data somewhat
imprecise, Japan (161, 23%), China (115, 17%), the Eastern
Atlantic (112, 16%), and the Mediterranean (91, 14%) stand
out as the major sources (479 in total, 69%) for reports of
halogenated organic molecules from these sources (Chart 3).
Table 1 presents the distribution of halogenated organic
molecules produced by the ten most productive species of the
family. These species have produced a total of 345 halogenated
compounds, accounting for 50% of those reported so far from
the family. The species Laurencia obtusa was the most proliﬁc
producer to date. A total of 98 halogenated molecules,
accounting for 14% of all 697 compounds described in this
review, were documented as metabolites of this species,
including sesquiterpenes, diterpenes, triterpenes/polyethers,
and ACGs (Table 1), demonstrating the presence of many
versatile enzymatic systems and biosynthetic pathways in this
species. Laurencia nipponica and Rhodomela confervoides stand as
the second and third most proliﬁc sources for production of
halogenated molecules, from which 45 and 41 halo-compounds
were reported, respectively. In contrast to L. obtusa, however,
species of Rh. confervoides appears to be narrower in their
biosynthetic capabilities, as all 41 compounds discovered from
Figure 52. Monoaryl bromophenolic derivatives (623−648).
Figure 53. Diaryl bromophenolic derivatives (649−663).
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this species in this review are halogenated phenolic derivatives
(Supporting Information Table S15). Among other species, it is
worthy of note that the halogenated organic molecules
produced by L. viridis and L. brongniartii are restricted to
triterpenes and indoles, respectively (Supporting Information
Table S15), which implies the presence of strict biosynthetic
pathways in these two species.
5. CHEMOTAXONOMIC SIGNIFICANCE
As noted earlier, the Rhodomelaceae is estimated to be the
largest red algal family with about 125 genera and some 700
species recognized worldwide.4 The taxonomy of this family
was widely studied, but is often complicated by high
morphological variability within individual species. However,
some morphological features are closely associated with
halogenated chemical constituents. The intracellular refractile
inclusion known as Corps en cerise (cherry body) that is usually
observed in superﬁcial cortical and trichoblast cells of Laurencia
species is a good example. Corps en cerise is recognized as a site
for the synthesis or storage of halogenated molecules,178,402,403
and it was reported that Laurencia species without Corps en
cerise do not produce halogenated metabolites.116 It was also
reported that most species in the genus Laurencia produce at
least one compound that is not found from any of the others.32
On the other hand, the occurrence of halogenated molecules in
a species is not random because chemical characteristics are
determined by its genome and corresponding enzymes,404,405
and halogenated metabolites of Laurencia origin were shown to
be under strict genetic control.264,405 Therefore, halogenated
organic molecules may be useful taxonomic markers for the
discrimination of species within the genus Laurencia.32,406 The
chemotaxonomic signiﬁcance of using these metabolites as
markers in place of heterosides, which were also used for this
purpose, is supported by the observation of a correlation
between the presence of terpenes and ﬂoridosides and between
the presence of bromophenols and digeneaside.407
The occurrence of halogenated molecules in the Rhodome-
laceae varies with genus and species, as discussed above. Species
of the genera Laurencia and Chondria mainly produce terpenes,
while members of the genera Halopytis, Odonthalia, Poly-
siphonia, Rhodomela, Symphyocladia, and Vidalia tend to form
bromophenols. In addition, Laurencia species also metabolize a
variety of C15-acetogenins.
Figure 54. Diaryl bromophenolic derivatives (664−683).
Figure 55. Triaryl (684−687) and tetra-aryl (688) bromophenolic derivatives.
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Chamigrane sesquiterpenes and C15-acetogenins are almost
ubiquitous in species of the genus Laurencia, but they have
never been reported from other genera of the family.24 L.
composita, similar to L. okamurai in gross morphology and
diﬃcult to distinguish, mainly produces halogenated bisabolane
(5)28 and chamigrane/rearranged chamigrane sesquiterpenes
(43, 245, and 246),28,177,405 but L. okamurai can produce both
chamigrane/rearranged chamigrane (51, 94, 95, and
244)61,86,176,408 and laurane/cuparane sesquiterpenes (128,
147−150, 167, and 168),110,130−132,408 as well as acetogenins
(432 and 530).280,334,335 Additionally, no oxygenated/halo-
genated acetogenins have been described to date as metabolites
of L. composita.177 It is also diﬃcult to distinguish L. tristicha
from L. okamurai morphologically, but L. tristicha produces
only chamigrane (145 and 146)129 and laurane/cuparane
sesquiterpenes (150, 151, and 158).133,135
While chamigrane sesquiterpenes are commonly isolated
from Laurencia species, rearranged structures with a methyl
migration from C11 to C10 have been found only in L.
pinnatif ida (243),175 L. okamurai (244),176 L. composita (245
and 246),177 L. pannosa (247 and 248),178 and an undescribed
Laurencia species (242).101 Sesquiterpenes with bisabolane
skeleton are abundant constituents of some Laurencia species,
such as L. scoparia (6−8),29 L. aldingensis (11−14),31,32 and L.
caespitosa (18−22),36 and may be used as eﬀective chemo-
taxonamic markers. In contrast, snyderane sesquiterpenes are
generally present in L. obtusa (172, 174−177, and
194),72,141,142,150 L. saitoi (186−188 and 209),147 L. f lexilis
(204−208),153,154 and L. luzonensis (181−184, 189−193, and
201−203).145,148,149 As for halogenated brasilane sesquiter-
penes, so far they have been isolated only from L. obtusa (25−
28),39,40 whereas halogenated eudesmanes (selinanes) are
unique to L. f iliformis (129, 132, and 133),111,115 L. intricata
(134),116 and L. microcladia (135).117 The above characteristic
sesquiterpene classes from various Laurencia species might be
useful as chemotaxonamic markers.
Diterpenes with unique skeletons are often characteristic of
certain Laurencia species.67,149,221,225,228 Irieane diterpenes were
solely isolated from L. irieii (276−284),189,190 L. pinnata (285−
287),191 L. decumbens (288),192,193 and more recently, from an
unrecorded Laurencia species (289),194 while parguerane
diterpenes having a modiﬁed pimarane skeleton were only
reported in L. obtusa (302−306),208−210 L. f iliformis (307−
Figure 56. Other halogenated organic molecules (689−697).
Chart 2. Distribution of the 697 Halogenated Organic
Molecules of Rhodomelaceae Origin as Shown by Structural
Classesa
aSTP, sesquiterpenes; DTP, diterpenes; TTP, triterpenes/polyethers;
ACG, acetogenins; IND, indoles; PHS, phenols/aromatics; ODS,
other derivatives.
Chart 3. Geographic Distribution of the 697 Halogenated
Organic Molecules of Rhodomelaceae Origin As Shown by
Sampling Sources
Table 1. Distribution of Halogenated Organic Molecules
Produced by the Ten Most Productive Species of the Algal
Family Rhodomelaceae
structural classc
speciesa,b STP DTP TTP ACG IND PHS ODS total
L. obtusa 42 17 6 33 98
L. nipponica 19 2 24 45
Rh. confervoides 41 41
L. majuscula 26 2 4 1 33
L. microcladia 8 6 10 24
L. glandulifera 11 1 12 24
L. pinnatif ida 7 1 14 22
L. viridis 19 2 21
L. brongniartii 20 20
L. f iliformis 11 6 17
total 124 34 26 97 20 41 3 345
aThe table was sorted using the total column on the basis of the
number of compounds produced by each species. bAbbreviation for
the genera: L. = Laurencia; Rh. = Rhodomela. cAbbreviation for the
compound classes: STP, sesquiterpenes; DTP, diterpenes; TTP,
triterpenes/polyethers; ACG, acetogenins; IND, indoles; PHS,
phenols/aromatics; ODS, other derivatives.
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312),211 L. nipponica (313 and 314),212 and L. saitoi (304 and
308).409 Additionally, labdane diquiterpenes are mainly found
in L. pinnata (292−295).200
Polyether triterpenes were found in several Laurencia
species,230 such as L. thyrsifera (347),231−233 L. venusta
(348),233 L. obtusa (349 and 351−355),234,235 L. pinnatif ida
(350),127 L. calliclada (356),236 L. viridis (357−366 and 372−
380),237−242,246−248 L. mariannensis (367 and 368),243 L.
intricata (389),254 and L. omaezakiana (387),250,251 as well as
in Chondria armata (369−371 and 381−386),245,249 while
polybromoindoles were reported only from L. brongniartii
(570−575, 578−583, and 589−596)352−354,356,358 L. decum-
bens (587),192 and L. similis (576, 577, and 584−586,
588),185,355,357 with those from L. brongniartii often containing
s u l f u r (570 , 571 , 574 , 578−580 , a nd 589−
596).352,353,356,358,410
Bromophenols with a 3-bromo-4,5-dihydroxybenzyl unit
(598,360 647, 667,381 668,194 678−683,391−394 and 688397)
are predominant in the genus Polysiphonia, especially in P.
urceolata (647, 667, 668, 678−683, and 688),194,381,391−394,397
while those with a 2,3-dibromo-4,5-dihydroxybenzyl unit are
characteristic of Rhodomela (608−615,363−366 617−624,367−369
651−658,363,365−369,383,384 669−671,365 677,368 686,363 and
687368) and Odonthalia (600,2 665,387 and 674389), and those
with a 2,3,6-tribromo-4,5-dihydroxybenzyl unit are typical of
Symphyocladia (629−635,370−374 645, 646,380 659−661,373,380
675,390 and 676373).
Despite of some of the characteristic metabolites were found
in certain species of the Rhodomelaceae family, it is interesting
to note that recollection of the same algal species at the same
site and the same season over the consecutive years does not
guarantee that only the same metabolites will be obtained.98 It
thus should be noted that, although the presence of these
halogenated molecules can be informative, it is not advisable to
rely solely on them to make taxonomic assignments, but instead
to combine consideration of chemical composition with
examination of morphological and cytological features.
6. SYNTHESIS
Because they possess a variety of novel structures and often
display potent biological activities, halogenated organic
molecules have attracted considerable attention as challenging
targets for partial and total synthesis. A number of elegant
synthetic strategies and methodologies were developed and
employed for the synthesis of such compounds. Pioneering
work in synthetic chemistry related to halogenated organic
molecules of Rhodomelaceae origin was carried out by the
Martiń group for the synthesis of β-snyderol (173)411 and the
Masamune group for the synthesis of (±)-laurencin
(451)412−414 in the 1970s. Several research groups including
those of Crimmins,415−420 Holmes,421−424 Kim,425−430 Mar-
tiń,411,431,432 and Overman433−439 also made great contribu-
tions to the synthesis of halogenated organic molecules of
Rhodomelaceae origin. To keep this review to a reasonable
length, it is not possible to describe all of the synthetic work
that could be considered relevant to this topic. In general, only
the ﬁrst total synthesis, or syntheses employing a new
methodology or a new strategy, are included in the present
review (Tables 2−5). These approaches are discussed in the
following sections.
6.1. Synthesis of Sesquiterpenes
6.1.1. Synthesis of Chamigrane Sesquiterpenes. The
spirobicarbocyclic chamigranes obtained from red algae of the
family Rhodomelaceae, especially from the genus Laurencia, are
the largest and most varied group among halogenated marine
Table 2. Synthesis of Halogenated Sesquiterpenes
compound synthetic strategy research group ref
chamigrane (−)-2,10-dibromo-3-hydroxy-α-
chamigrene ((−)-90)
bromonium-initiated intramolecular carbocyclization Martiń 432
15-bromo-1,3(15),7-chamigrren-9-one
((±)-108)
spiroannelation from anisole Niwa 440
laurane allolaurinterol (138) controlling the regiochemistry by using of metalated phenyl
methoxymethyl ethers
Ronald 441
isolaurinterol (142) and isoaplysin
(147)
diastereoselective radical-to-polar crossover sequence Harrowven 442,
443
ﬁliforminol (153) and bromoether A
(154)
copper-catalyzed conjugate addition and subsequent metylation,
epoxidation, and spontaneous cyclization
Yoo 444
snyderane β-snyderol (173) bromonium ion-induced cyclization of methyl farnesate Gonzaĺez 411
palisadins A (195), B (196), and 12-
hydroxypalisadin B (198)
formation of trans-anti-cyclogeranyl-oxepene systems by
stereoselective coupling and ring-closing metathesis
Couladouros 445
sesquiterpenes with new
carbon skeletons
(±)-oppositol ((±)-216) doubly diastereodiﬀerentiating “folding and allylic strain-
controlled” intramolecular ester enolate alkylation
Kim 425
(±)-spirolaurenone ((±)-240) eﬃcient cyclization of geranonitrile promoted by boron triﬂuoride-
acetic acid
Masamune 446
Scheme 1. Total Synthesis of (±)-15-Bromo-1,3(15),7-Chamigratrien-9-one ((±)-108) by Niwa et al.440
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natural products. Spirocycles represent challenging synthetic
targets, and installation of a quaternary carbon adjacent to the
spirocenter oﬀers an excellent fundamental test of synthetic
methodology.411
In 1986, Martiń and colleagues accomplished the enantio-
selective total synthesis of (−)-2β,10β-dibromo-α-chamigren-
3α-ol (90) (Table 2).432 The synthesis features asymmetric
induction in the bromonium-initiated intramolecular carbocyc-
lization reaction as the key strategy which was achieved by
generation of exocyclic alkylidienes containing two stereogenic
atoms located on the cyclohexene ring. This asymmetric
methodology represents a general strategy for the enantiose-
lective construction of spiro[5,5]undecane systems containing a
chiral quaternary center, which is useful for the synthesis of a
wide variety of six-membered spirocycle-containing natural
products.
In 1991, Niwa and co-workers described the total synthesis
of (±)-15-bromo-1,3(15),7-chamigratrien-9-one ((±)-108)
using anisole as starting material (Scheme 1).440 The desired
intermediate 5-(4-methoxyphenyl)-5-methylhexan-1-ol was
prepared eﬃciently by Friedel−Crafts reaction of anisole with
5-methyl-1,5-hexanediol in nearly quantitative yield with a
single step. Upon Birch reduction and Swern oxidation, 5-
methyl-5-(4-oxocyclohex-1-enyl)hexanal (108a) was obtained
as a key intermediate, which was then subjected to
spiroannelation and oxidation to aﬀord a spiro diketone as a
second key intermediate 108b that possessed the spiro[5.5]-
undecane skeleton. The target compound 108 was ﬁnally
obtained by a series of further reactions including alkylation,
reduction with Zn in AcOH, dehydration with SOCl2-pyridine,
and oxidation in the presence of CrO3 (Scheme 1).
440 The key
step in the synthesis was construction of the spiro[5.5]-
undecane skeleton.
6.1.2. Synthesis of Laurane and Snyderane Sesqui-
terpenes. 6.1.2.1. Synthesis of Laurane Sesquiterpenes. In
1982, Gewali and Ronald accomplished the ﬁrst synthesis of
allolaurinterol (138) starting from 3-(methoxymethoxy)toluene
(138a) using metalated phenyl methoxymethyl ethers to
control the regiochemistry as the key strategy (Scheme 2).441
The key tricyclic carbinol 138b was synthesized from 138a and
then the hydroxyl group of 138b was replaced by a methyl
group to aﬀord 138c through three conversion steps, with ﬁrst
to be the chlorination with PCl3 to yield the highly reactive and
sensitive tricyclic chloride, which was followed immediately by
alkylation with CH3MgBr, and the resulting oleﬁn was then
hydrogenated over platinum to yield the tricyclic ether 138c.
The furanoid ring of 138c was opened with lithium
tetramethylpiperidide in reﬂuxing THF, which was proved to
be the best procedure to induce clean elimination to aﬀord the
phenolic oleﬁn 138d. Subsequent functionality at C3 in the
cyclopentane ring yielding the oleﬁn 138e in ﬁve steps and
deprotection of 138e with n-Bu4NF in THF aﬀorded the target
compound allolaurinterol (138).441
In 1999, isolaurinterol (142) and a series of related
sesquiterpenes were synthesized by Harrowven and col-
leagues.442 The synthesis features a diastereoselective radical-
to-polar crossover sequence to transform the diene into
debromoisolaurinterol. This methodology was successfully
used to the total synthesis of (±)-isoaplysin (147) and other
related sesquiterpenes of the laurane class.443 In 1998, Yoo and
co-workers described the concise total synthesis of (±)-ﬁl-
iforminol (153) and (±)-bromoether A (154) starting from 3-
methylcyclopent-2-en-1-one through the use of a bromonium
ion-initiated cyclization strategy.444 Key methodology and steps
used in the synthesis included copper-catalyzed conjugate
addition and subsequent methylation, epoxidation, and
spontaneous cyclization.
6.1.2.2. Synthesis of Snyderane Sesquiterpenes. Martiń and
co-workers developed an approach to selective C−Br bond
formation with concomitant ring closure in 1976.411 As a result,
a simple synthesis of β-snyderol (173) was carried out
involving bromonium ion-induced carbocyclization of an
acyclic polyene. In 2004, palisadins A (195) and B (196) and
12-hydroxypalisadin B (198) were eﬃciently generated by
Couladouros and Vidali using a general stereocontrolled
strategy for the construction of cyclogeranyl-oxepenes employ-
ing a process involving epoxide opening by a tertiary alcohol
and subsequent ring-closing metathesis.445
Scheme 2. Total Synthesis of Allolaurinterol (138) by Gewali and Ronald441
Scheme 3. Stereoselective Total Synthesis of (±)-Oppositol (216) by Kim et al.425
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6.1.3. Synthesis of Sesquiterpenes with New Carbon
Skeletons. In 1997, Kim’s group accomplished a stereo-
selective total synthesis of (±)-oppositol (216) involving 16
steps starting from an α,β-unsaturated ester.425 The synthesis
featured a novel, doubly diastereodiﬀerentiating “folding and
allylic strain-controlled” intramolecular ester enolate alkylation
(Scheme 3). In 1982, Murai and co-workers achieved the ﬁrst
total synthesis of (±)-spirolaurenone (240) in 13 steps with an
overall yield of 2.4% from the bromohydrin of homogeranoni-
trile.446 The synthesis, which was based on the eﬃcient
cyclization of geranonitrile, also conﬁrmed the R-conﬁguration
at C2 for the compound.
6.2. Synthesis of Diterpenes
Compared to the synthesis of sesquiterpenes, much less work
was described regarding the synthesis of diterpenes of
Rhodomelaceae origin. In 1987, Masamune and co-workers
described a stereoselective synthesis of the bromditerpene
Table 3. Synthesis of Diterpenes and Triterpenes
compound synthesis strategy
research
group ref
diterpenes (±)-prepinnaterpene (334) construction of the brominated bicyclic skeleton involves acid-catalyzed epimerization of a cis-
hydrindane system to the corresponding trans isomer and a pivotal Finkelstein reaction for bromine
introduction as key steps, then installation of the respective diene units through Wittig reaction.
Masamune 447
triterpene/
polyethers
(+)-thyrsiferol (347), (+)-ve-
nustatriol (348), and
(+)-thyrsiferyl 23-acetate
(349)
stereoselective epoxidation of the 4-en-1-ol system and successive cyclization to form the D ring, with
construction of the A ring by bromonium ion-induced cyclization of the 4-en-ol system
Shirahama 448
thyrsiferol (347) and thyrsi-
feryl 23-acetate (349)
early joining of intermediates containing the A and C rings followed by formation of the B ring;
construction of the D ring by a highly stereoselective Re(VII)-promoted syn-oxidative cyclization of
bis-homoallylic alcohol
Forsyth 451
venustatriol (348) stereospeciﬁc formation of the tetrahydrofuran ring (the D ring) by PCC oxidation Corey 452
ent-dioxepandehydrothyrsifer-
ol (380)
construction of the 7,7,6-fused tricyclic polyether framework by a single bromonium-initiated epoxide-
openings
Jamison 453
(+)-intricatetraol (389) enantioselective construction of the vicinal bromochloro functionality Morimoto 454
Scheme 4. Three Strategies for the Syntheses of Halogenated Triterpenes/Polyethers
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(±)-prepinnaterpene (334) in 32 steps with 2.6% overall yield
starting from readily available trans-octalin-1,4-dione (Table
3).447 A synthesis of the structurally related sesquiterpene
oppositol ((±)-216) was also described in the same report. The
synthesis of 334 features an acid-catalyzed epimerization of a
cis-hydrindane system to the corresponding trans isomer and a
pivotal Finkelstein reaction for bromine introduction as key
steps.
6.3. Synthesis of Triterpenes
6.3.1. Synthesis of Thyrsiferol and Its Derivatives. The
structurally complex and densely functionalized nature of the
triterpenoid polyether thyrsiferol (347) and its derivatives,
which possess common structural features including a
bromotetrahydropyran unit (A ring), a core pyranopyran
moiety (BC rings), and a tetrahydrofuran segment (D ring),
makes the construction of the corresponding skeleton a very
challenging task. Although the tactical details are distinctive to
each synthetic team (Table 3), most of the synthetic eﬀorts
directed toward these compounds can be categorized, based on
the sequence of constructing the four rings, into three major
strategies (Strategies I−III), as illustrated in Scheme 4.
“Strategy I” features initial construction of the central BC
ring system, followed by elongation of the side-chain to form
the D ring, and ﬁnally formation of the A ring, while “Strategy
II” involves connection of two tetrahydropyran-containing units
representing the functionalized A and C rings, annulation of the
B ring to form the ABC tricyclic system, and then attachment
of the D ring through installation of the C15−C16 carbon−
carbon bond via coupling an aldehyde with an iodide. “Strategy
III” adopts construction of the central BC ring system, followed
by formation of the A ring, and installation of the side-chain to
form the D ring.
In 1990, Shirahama’s group accomplished the ﬁrst total
synthesis of (+)-thyrsiferol (347), (+)-venustatriol (348), and
(+)-thyrsiferyl 23-acetate (349) in a stereoselective manner via
“Strategy I” (Scheme 5).448−450 The processes for these
syntheses included (1) construction of the BC ring system
with a C1−C6 carbon unit, (2) elongation of the C17−C24
carbon side-chain, (3) formation of the D ring through
stereoselective epoxidation of the 4-en-1-ol system and
successive cyclization, and ﬁnally, (4) construction of the A
ring by bromonium ion-induced cyclization of the 4-en-ol
system.
“Strategy II”, developed by Gonzaĺez and Forsyth, was also
applied to the total syntheses of thyrsiferol (347) and
thyrsiferyl 23-acetate (349) (Scheme 6).451 The synthesis
Scheme 5. Total Synthesis of (+)-Thyrsiferol (347), (+)-Venustatriol (348), and (+)-Thyrsiferyl 23-acetate (349) by Shirahama
et al.448
Scheme 6. Total Syntheses of Thyrsiferol (347) and Thyrsiferyl 23-Acetate (349) via Strategy II, by Gonzaĺez and Forsyth451
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features the separate construction of two advanced inter-
mediates representing the C1−C15 (349a) and C16−C24 (349b)
domains, followed by their organochromium-mediated cou-
pling, installation of the tertiary alcohol at C15, and
manipulation of the C18 and C23 acetate moieties. The early
incorporation of intermediates containing the A and C rings,
followed by an eﬃcient annulation of the B ring, as well as
convergent attachment of the D ring intermediate and minimal
manipulation of hydroxyl-protecting groups, reﬂects the
ﬂexibility and eﬃciency of the synthesis.
In 1988, Corey and Ha employed “Strategy III” to
accomplish an enantioselective and convergent total synthesis
of venustatriol (348) via key intermediates 349a and 348c
(Scheme 7a).452 The synthesis involves a number of highly
stereoselective steps, with the tris-homoallylic epoxidation from
348d to 348e and the conversion of 348f to 348g by PCC
being especially noteworthy (Scheme 7b).
In 2009, Jamison and co-workers described an enantiose-
lective total synthesis and absolute conﬁguration conﬁrmation
of ent-dioxepandehydrothyrsiferol (380) starting from (E,E)-
farnesol (380a).453 The synthesis features the only example to
date of the construction of the 7,7,6-fused tricyclic polyether
framework by a single bromonium-initiated epoxide-opening
cascade, which incorporates both endo- and exo-selective
epoxide openings (Scheme 8). This work also represents the
ﬁrst total synthesis of any natural product with the trans-anti-
trans fused tricyclic motif.
6.3.2. Synthesis of (+)-Intricatetraol. In 2007, Morimoto
and co-workers described the ﬁrst asymmetric total synthesis of
the symmetrical bromochlorotriterpene (+)-intricatetraol
(389).454 The synthesis, which enabled the absolute conﬁg-
uration of this compound to be unambiguously assigned,
features the enantioselective construction of the vicinal
bromochloro functionality in an approach that may be
applicable to the synthesis of other bromochloro compounds.
6.4. Synthesis of C15-Acetogenins (ACGs)
In addition to the synthetic eﬀorts directed toward the
production of halogenated terpenes, syntheses of halogenated
ACGs also attracted considerable attention from synthetic
Scheme 7. (a) Total Synthesis of Venustatriol (348) via Strategy III, by Corey and Ha452 and (b) Highly Stereoselective
Reactions Reported in Total Synthesis of Venustatriol (348) by Corey and Ha452
Scheme 8. Enantioselective Total Synthesis of (ent)-Dioxepandehydrothyrsiferol ((ent)-380) by Jamison et al.453
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chemists due to distinctive structural features such as the
medium- to large-sized ether ring skeleton, substitution of
halogen atoms adjacent to an ether oxygen atom, and a
bromoallene or an enyne side-chain.412−421,429,430,434−439
Various strategies were explored with particular attention to
construction of the entropically disfavored medium ring
ether(s), and a number of ACGs having medium-sized ring
cores were successfully synthesized (Table 4). However,
syntheses of ACGs possessing larger-ring ether systems such
as obtusallene derivatives (537−549) were not reported.
6.4.1. Synthesis of ACGs Containing Tetrahydrofuran
Structural Units. Kumausyne (403) was selected as the most
important target compound for the synthesis of tetrahydrofur-
an-containing ACGs and many research groups have reported
elegant strategies/methodologies for the synthesis of this
compound (Table 4).434,456−463 In 1991, Overman and co-
workers accomplished the landmark total synthesis of
(±)-trans-kumausyne (403). Starting from (1R*,2S*)-1-vinyl-
cyclopentane-l,2-diol (403a), the synthetic sequence aﬀorded
(±)-403 in 15 steps and 2.7% overall yield, and employed a
novel Prins cyclization-pinacol rearrangement for elaborating
the tetrahydrofuran core (Scheme 9).434 The key rac-hydro-
benzofuranone intermediate 403b was conveniently formed on
a large scale and with complete stereocontrol via a “ring-
enlarging tetrahydrofuran annulation”, by the acid-catalyzed
condensation of 403a and α-(benzyloxy)acetaldehyde, while
intermediate 403c was conjoined with the six-carbon side chain,
and the lactone function of 403e was then manipulated to
elaborate the ﬁve-carbon side chain to construct the main
skeleton. In 1997, Landais’ group approached the total
synthesis of (±)-trans-kumausyne (403) via another strategy
featuring the construction of tetrahydrofurans in good yield and
diastereoselectivities with excellent 1,3-stereocontrol using
electrophilic 5-exo-trig cyclizations of 2-silyl-4-alkenols.455
The synthesis led to the formation of four chiral centers with
excellent diastereoselectivities. Chandler and Phillips later
described a diﬀerent, concise 19-step synthesis of (±)-403 in
2005.456 Noteworthy features of the latter synthesis include a
tandem ring-opening-ring-closing reaction that converts a
structure derived from furan and methyl acrylate by Diels−
Alder reaction into an advanced intermediate, a highly selective
Baeyer−Villiger reaction, and the use of cross metathesis for the
elaboration of a homoallylic alcohol into the pentenyl side-
chain.
In 1998, Boukouvalas and co-workers accomplished a more
concise and eﬃcient synthesis of (−)-403 starting from
dimethyl (R)-malate in 13 steps and 6.2% overall yield
(Scheme 10).459 The synthesis features Pd(II)-mediated
intramolecular alkoxycarbonylation-lactonization of an enediol
to aﬀord the bicyclic lactone core of the key intermediate
(403f) in an atom-economical fashion.
In 2001, Gadikota and co-workers developed a concise route
for the total synthesis of (+)-trans-kumausyne (403) and other
related marine natural products from D-arabinose using a
general strategy for the construction of a 2,3,5-trisubstituted
tetrahydrofuran unit via a regioselective hydride ring-opening of
the epoxide moiety in the readily accessible methyl 2,3-
anhydro-5-O-benzyl-α-D-lyxofuranoside.462 In contrast, Fernań-
dez de la Pradilla and co-workers described a uniﬁed formal
synthesis of enantiopure (+)-403 in 1998 employing a highly
stereoselective remote nucleophilic epoxidation of a sulﬁnyl
diene moiety to construct the tetrahydrofuran template.463 This
methodology was successfully applied to the preparation of
(+)-kumausallene (431), one of the 2,6-dioxabicyclo[3.3.0]-
octane-containing ACGs.463
In 1997, Martiń and co-workers described a convergent and
stereocontrolled 22-step synthesis of (+)-trans-deacetylkumau-
syne (404).464 The approach started with propargyl alcohol and
employed brominative cyclization as a key step to obtain the
tetrahydrofuran core.
Scheme 9. Total Synthesis of (±)-trans-Kumausyne (403) Starting from (1R*,2S*)-1-Vinylcyclopentane-1,2-diol (403a) by
Overman et al.434
Scheme 10. Synthesis of (−)-trans-Kumausyne (403) Starting from Dimethyl (R)-malate by Boukouvalas et al.459
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In 1993, Overman’s group reported the ﬁrst total synthesis of
(±)-kumausallene (431), a 2,6-dioxabicyclo[3.3.0]octane-con-
taining ACG, employing cis-hydrobenzofuranone as a key
intermediate obtained from 1-vinylcyclopentane-1,2-diol and α-
(benzyloxy)-acetaldehyde via Prins cyclization-pinacol rear-
rangement strategy.437 The synthesis proceeded in 17 steps and
2% overall yield from hydrobenzofuranone. In 1998, Lee and
co-workers described a formal synthesis of (−)-431 in 16 steps
starting from (−)-diethyl D-tartrate via enantiomerically pure
2,6-dioxabicyclo[3.3.0]octane as the key intermediate,465 and
completing the ﬁnal portion of the synthesis following
Overman’s route.437 This procedure provided an interesting
example of the radical cyclization of β-alkoxyacrylates. The ﬁrst
enantioselective synthesis of (−)-431 was accomplished by
Evans and co-workers in 1999 involving 14 steps through the
intermediacy of a bicyclic lactone prepared from enantiomeri-
cally enriched 1,3-butanediol (Scheme 11).466 This synthesis
demonstrated that the bromoallene moiety is compatible with
multiple synthetic operations and led to unambiguous assign-
ment of the absolute conﬁguration of the bromoallene. A
similar strategy could, in principle, be adapted to facilitate the
preparation of other related tetrahydrofuran-containing
ACGs.446
6.4.2. Synthesis of Seven-Membered Cyclic ACGs. In
2001, Suzuki and co-workers achieved the ﬁrst total synthesis of
(+)-rogioloxepane A (443) with high stereoselectivity.467 This
synthesis showed that the cyclization of hydroxy epoxides
promoted by the (Bu3Sn)2O/Zn(OTf)2 system is an eﬃcient
methodology for the preparation of highly functionalized seven-
membered oxacyclics. In addition, the synthesis conﬁrmed the
6R and 13R conﬁgurations for 443. In 2003, Crimmins and
DeBaillie disclosed the enantioselective total synthesis of
(+)-443 in 21 steps starting from 1,5-hexadien-3-ol.419 The
establishment of the trans-disubstituted oxepene ring through
the use of a combination of asymmetric glycolate alkylation and
a ring-closing metathesis comprise the key steps in the
synthesis.
In 1992, Berger and Overman described the eﬃcient
synthesis of isolaurepinnacin (446) by Lewis acid-promoted
cyclizations of β-chloro- (or β-bromo-) acetals starting from 1-
methoxy-1-heptene and silylpentenol.435 The ﬁrst total syn-
thesis of (+)-446 was later reported by the same group with
high stereoselectivity in 12 steps and 15% overall yield from cis-
2-penten-1-ol.436,439 The synthesis features an acetal-vinylsilane
cyclization to stereoselectively form the cis-2,7-disubstituted
oxepene ring and introduce Δ4 unsaturation. This synthesis
rigorously established the S conﬁguration of 446 at C13, and the
report also corrected the rotation of the natural 446 to be
dextrorotatory. In 2001, Suzuki’s group accomplished a formal
synthesis of (+)-446 with high stereoselectivity.468 The
approach featured stereoselective construction of the oxepene
core employing cyclization of a hydroxy epoxide promoted by
the (Bu3Sn)2O/Zn(OTf)2 system.
In 2005, Kim’s group accomplished a highly stereoselective
and concise total synthesis of (−)-isoprelaurefucin (447) from
oxirane in 14 steps and 12% overall yield. The approach
employed a strategy involving a novel “protecting group-
dependent” alkylation and ring closing metathesis to form the
oxepene core.429 The ﬁrst asymmetric total synthesis of
(+)-neoisoprelaurefucin (449) was developed in 2003 by
Kim’s group in 20 steps and 2.9% overall yield (Scheme 12).427
The key intermediate 449b was obtained by using a novel ﬁve-
step sequence involving bromolactonization of α,β-unsaturated
amide 449a with NBS, stereoselective debromination with n-
Bu3SnH, addition of EtMgBr to the γ-lactone, stereoselective
reduction of the resulting hemiketal-ketone mixture (3:1), and
Scheme 11. Enantioselective Synthesis of (−)-Kumausallene (431) by Evans et al.466
Scheme 12. Asymmetric Total Synthesis of (+)-Neoisoprelaurefucin (449) by Kim et al.427
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ﬁnally, elimination of syn-silyl alcohol by treatment with
potassium t-butoxide in THF. The approach features an
eﬃcient internal alkylation of an amide to form the oxepene
skeleton with good regio- and stereocontrol, a novel sequence
for removal of a triethylsilyl group from a vinylsilane, and a
stereoselective bromoetheriﬁcation of an alcohol. The synthesis
also established the absolute conﬁguration of the natural
(+)-449.
6.4.3. Synthesis of ACGs Containing Eight-Membered
Cyclic Ether Cores. Two strategies were commonly used for
the synthesis of ACGs containing an eight-membered cyclic
ether unit, with one route employing the cyclization of an
acyclic precursor and another (the more popular one) relying
on elaboration of eight-membered lactone precursors.398
Starting in 1977, much attention was focused on eﬃcient
approaches toward the synthesis of (±)- and (+)-laurencin
(451). The interesting structure of this compound made it an
attractive target for synthetic organic chemists on which to test
new strategies for stereoselective construction of eight-
membered ring ethers. Pioneering work in this area was carried
out by Masamune and co-workers as exempliﬁed by the ﬁrst
total synthesis of (±)-laurencin (451).412−414 The synthesis
was based on Robinson-Schöf condensation to form a 9-aza-3-
oxabicyclo[3.3.1]nonane framework and subsequent ring-
expansion employing a Hoﬀman elimination.
In 1993, Holmes’ group described the enantioselective
synthesis of (+)-451 in 26 steps from dimethyl (R)-malate
(451a) using a Claisen rearrangement approach to a key
lactone intermediate (451b).423 Noteworthy steps include the
reagent-controlled diastereoselective enolate oxidation, the
carbon homologation sequence involving Tebbe methylenation
of 451b and diastereoselective intramolecular hydrosilation, the
stereocontrolled introduction of the pentenynyl side-chain, and
a remarkably high-yielding displacement of the secondary
alcohol by bromide ion (Scheme 13).423 Later in 1997, the
Holmes group achieved another enantioselective synthesis of
(+)-451 in 27 steps from (R)-malic acid.424 The key steps
involved methylenation of the corresponding lactone followed
by intramolecular hydrosilylation of the enol ether and one-
carbon homologation of the related diol to give an ethyl-
substituted cyclic ether core as the key intermediate. The
lactone, in turn, was obtained by two eﬃcient routes including
those of a Claisen-ring-expansion followed by α-hydroxylation,
and a Yamaguchi lactonization.
In 1995, Overman’s group accomplished the enantioselective
total synthesis of (+)-451 from allyl alcohol in 24 steps and 2%
overall yield.438 The synthesis features an acetal-vinyl sulﬁde
cyclization that forms the oxocene ring directly, and introduces,
with complete control, the Δ4 unsaturation and requisite
functionality at C3, C4, and C9.
In 1999, Crimmins and Choy reported a method for
asymmetric construction of medium-ring cyclic ethers by
merging the asymmetric aldol addition of glycolates with a
ring-closing metathesis reaction which provided eﬃcient entry
to a variety of cyclic ethers.415 Application of this strategy led to
a short formal synthesis of (+)-451. The Crimmins’ group also
developed an original route for the enantioselective total
synthesis of (+)-451 in the same year, where three of the four
stereocenters of 451 were provided by asymmetric alkylation
and aldol reactions.416 The synthesis involves 18 steps from S-
(+)-4-benzyl-3-benzyloxyacetyl-2-oxazolidinone and the key
steps included an asymmetric glycolate alkylation leading to
an acyl oxazolidinone and a subsequent ring-closing oleﬁn
metathesis to construct the oxocene core. The strategy utilized
in this synthesis provides a general and eﬃcient route to
medium-sized cyclic ether cores of other marine natural
products. In 2005, Fujiwara and co-workers achieved the
eﬃcient synthesis of (+)-451 starting from a C-galactoside
derivative, based on the ring expansion of the oxane part of the
starting material into an eight-membered ring ether via a ring-
cleavage/ring-closing metathesis process, followed by stereo-
selective introduction of a bromo group at C4, and, ﬁnally,
Scheme 13. Enantioselective Synthesis of (+)-Laurencin (451) by Holmes et al.423
Scheme 14. Asymmetric Total Synthesis of (−)-Laurefucin (465) by Kim et al.471
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convergent construction of the side-chain using a lithiated
enyne unit.469 In the same year, Kim and co-workers described
a new, eﬃcient, and highly stereoselective total synthesis of
(+)-451 from the known oxazolidinone in 15 steps and 5.4%
overall yield. The approach features an eﬃcient oleﬁn
geometry-dependent internal alkylation methodology for the
construction of eight-membered ether rings and a novel use of
acetonitrile anion as an acetaldehyde equivalent for the direct
synthesis of a ketone from an α-alkoxy N,N-dimethylamide.428
In 1996, Palenzuela and co-workers described a formal
synthesis of (+)- and (−)-451 using a hetero Diels−Alder
reaction between a monoactivated diene and (S)-(−)-2,3-O-
isopropylidene-glyceraldehyde (or its enantiomer) as the key
step.470
Recently, Kim and co-workers accomplished the ﬁrst and
highly stereoselective total synthesis of (−)-laurefucin (465) in
nine steps with 31% overall yield from known oxocene 465a.471
The key step in the synthesis features a novel and eﬃcient
organoselenium-mediated biomimetic-type intramolecular hy-
droxyetheriﬁcation (Scheme 14).
In 2007, Suzuki and co-workers reported the ﬁrst total
synthesis of (+)-(Z)-laureatin (481) with high stereoselectiv-
ity.472 The 3,8-dioxabicyclo[5.1.1]nonane skeleton possessing
trans-oriented alkyl substituents at the α,α′-positions to the
ether linkage was stereoselectively constructed by formation of
the oxetane via 4-exo cyclization of a hydroxy epoxide unit on
the oxocene core. In the same year, Kim’s group accomplished
the ﬁrst highly stereo-, regio-, and chemoselective asymmetric
total syntheses of (+)-3-(Z)-laureatin (481) and (+)-3-(Z)-
isolaureatin (482) in a completely substrate-controlled
manner.430 The syntheses feature an intramolecular amide
enolate alkylation to construct the α,α′-cis-oxocene skeleton,
novel “lone pair-lone pair interaction-controlled” epimeriza-
tions to give the α,α′-trans-oxocenes, various strategies for the
stereoselectively demanding introduction of halogen atoms, and
novel oleﬁn cross-metatheses for construction of the (Z)-enyne
systems.
Crimmins and Tabet achieved the ﬁrst total synthesis of
(+)-prelaureatin (485) in 2000.473 The versatile and eﬃcient
strategy for the synthesis involved asymmetric glycolate aldol
addition following by a ring-closing metathesis to form the
eight-membered ring, allowing construction of the oxocene
core. Treatment of (+)-485 with tetrabromocyclohexadienone
according to the procedure described by Murai474 yielded
(+)-laurallene (510).473 In 2002, Fujiwara and co-workers also
described a total synthesis of 485 featuring stereoselective
introduction of two allyl groups starting from galactose
pentaacetate, cleavage of the hexose ring, and transformation
of an acyclic triene into an oxocene by selective ring-closing
metathesis.475
In 1988, Overman and Thompson approached the ﬁrst total
synthesis of (−)-laurenyne (487) via a linear sequence that
proceeded in 20 steps and 0.6% overall yield starting from (1-
bromovinyl)trimethylsilane 487a (Scheme 15).433 The syn-
thesis is both enantioselective and highly stereocontrolled. The
key step was acetal-initiated cyclization to prepare the
functionalized eight-membered cyclic ether core, together
with the introduction of the Δ4-unsaturation and the cis-
oriented side-chain. The total synthesis also corrected the
absolute conﬁguration of natural 487 to be 2R, 7R, and 8R. In
2002, Boeckman and co-workers disclosed a novel asymmetric
total synthesis of the natural enantiomer (+)-487.476 The key
methodologies applied in the synthesis were a completely
diastereoselective metal ion-templated SN2′ cyclization aﬀord-
ing a highly functionalized chiral vinyl cyclobutane, and a retro-
Claisen rearrangement of the derived homochiral cyclobutane
dicarboxaldehyde yielding the eight-membered ring ether core.
In 2003, Kim’s group achieved the ﬁrst and highly
stereoselective asymmetric total syntheses of (+)-3-(Z)-
pinnatiﬁdenyne (496) and (+)-3-(E)-pinnatiﬁdenyne (497)
Scheme 15. Total Synthesis of (−)-Laurenyne (487) by Overman and Thompson433
Scheme 16. Asymmetric Synthesis of (+)-(3Z)- and (+)-(3E)-Pinnatiﬁdenyne (496 and 497) by Kim et al.426
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in 23 steps starting from the known epoxy alcohol (2R,3S)-1,2-
epoxy-4-penten-3-ol with 9.5% and 7.1% overall yields,
respectively (Scheme 16).426 Notable features of the syntheses
include novel and eﬃcient construction of the oxocene core via
a highly stereo- and regioselective internal alkylation, and direct
ketone synthesis from an α-alkyloxy amide moiety in the
oxocene.
In 2003, Suzuki’s group accomplished a high stereoselective
total synthesis of (+)-laurallene (510).477 The oxocene core
possessing trans-oriented alkyl substituents at the α,α′-positions
was stereoselectively constructed via the cyclization of the
corresponding hydroxy epoxide promoted by Eu(fod)3.
6.4.4. Synthesis of ACGs Containing Nine-Membered
Cyclic Ether Cores. In 1999, Murai and co-workers
accomplished the ﬁrst total synthesis of (+)-obtusenyne
(526).478 The synthesis employs cyclic enol ether formation
from the corresponding lactone, regio- and stereoselective
epoxidation of the cyclic enol ether, and stereoselective DIBAL-
H reduction of the epoxide as the key steps for the construction
of the nine-membered cyclic ether core. In 2003, Crimmins and
Powell completed a concise and highly diastereoselective
synthesis of (+)-526 in 20 linear steps from commercially
available 1,5-hexadiene-3-ol.420 The key steps were a Sharpless
kinetic resolution and an asymmetric glycolate alkylation to
establish the stereochemical relationship of the α,α′-disub-
stituted ether linkage, and a ring-closing metathesis to construct
the nine-membered oxocene. In 2007, Suzuki and co-workers
accomplished the highly stereoselective total synthesis of
(+)-526 starting from (+)-diethyl tartrate.479 The synthesis
features stereoselective construction of the oxonene core via
cyclization of the corresponding hydroxy epoxide promoted by
Eu(fod)3.
In 2001 and 2002, Crimmins and co-workers accomplished
the total synthesis of (−)-isolaurallene (529) starting from a
glycolic acid derivative.417,418 The core structure, a nine-
membered cyclic ether ring fused with a bromoallene-
substituted tetrahydrofuran, was constructed by a series of
reactions including asymmetric glycolate alkylation, Brown
asymmetric allylation, ring-closing metathesis, and bromoallene
formation via SN2′ displacement with LiCuBr2.
In 2010, Kim and co-workers reported a substrate-controlled
approach leading to the ﬁrst asymmetric total synthesis and
structure revision of (+)-itomanallene A (531).336 The key
steps involved in this approach were ring-closing metathesis
(RCM) and a highly stereoselective intermolecular amide
enolate alkylation (IAEA) to form the nine-membered-ring
ether. In this approach, known PMB-protected (S)-glycidol
531a was chosen as the starting material. After construction of
the dioxabicyclic skeleton using the RCM/IAEA strategy, the
bromoallene unit was installed via ﬁve steps (Scheme 17). This
approach provides a general strategy for the synthesis of both
α,α′-cis- and α,α′-trans-tetrahydrofurans in dioxabicyclic
oxonene marine natural products and related structures.
Some ineﬃciency in the ring-closing metathesis step was
overcome by modifying the synthetic route to incorporate the
tetrahydrofuran ring at an earlier stage.336
6.4.5. Synthesis of Maneonene and Isomaneonene
ACGs. Holmes and co-workers reported the ﬁrst total synthesis
of cis-maneonenes A (551) and B (552) employing selective
catalytic hydrogenation of a silylated butadiyne derivative,
which was, in turn, derived from bis(trimethylsily)butadiyne.421
Later, in 1984, trans-maneonene B (553) was prepared by the
same group using a similar route.422
6.5. Synthesis of Bromoindoles
In 2002, Liu and Gribble reported simple syntheses of
bromoindoles 581 and 583 starting from indole in 72% and
60% overall yields, respectively (Table 5).480 The syntheses
Scheme 17. Substrate-Controlled Asymmetric Total Synthesis and Structure Revision of (+)-Itomanallene A (531) by Kim et
al.336
Table 5. Synthesis of Halogenated Indoles and Phenols/Aromatics
compound synthetic strategy
research
group ref
bromoindoles 2,3,5,6-tetrabromoindole
(575)
sequential one-pot bromination-aromatization-bromination reactions to yield the key
intermediate, N-carbomethoxy-2,3,5-tribromoindole
Suaŕez-
Castillo
481
N-methyl-2,3,6-
tetrabromoindole (581)
selective bromination of the key intermediate, 2,3-dibromo-1-methylindole, which was
prepared from indole in a one-pot operation
Gribble 480
incorporation of bromine atoms at C2, C3, and C6 via bromination of N-carbomethoxyindole Suaŕez-
Castillo
481
N-methyl-2,3,5-
tetrabromoindole (582)
sequential one-pot bromination-aromatization-bromination reactions to yield the key
intermediate, N-carbomethoxy-2,3,5-tribromoindole
Suaŕez-
Castillo
481
N-methyl-2,3,5,6-
tetrabromoindole (583)
selective bromination of the key intermediate, 2,3-dibromo-1-methylindole, which was
prepared from indole in a one-pot operation
Gribble 480
bromophenols (±)-polysiphenol (680) highly regioselective intramolecular oxidative coupling Braddock 482
cyclotribromoveratrylene
(684)
coupling reaction promoted by triﬂuoro-acetic acid Keehn 484
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were readily achieved by selective bromination of the key
intermediate, 2,3-dibromo-1-methylindole, which in turn was
prepared from indole in a one-pot operation in 92% yield. In
2006, Suaŕez-Castillo and co-workers described a high-yielding
and regioselective synthesis of polybrominated indoles 575,
581, and 582.481 N-Carbomethoxyindoline was utilized as
starting material to synthesize 575 and 582 via sequential one-
pot bromination-aromatization-bromination reactions to yield
N-carbomethoxy-2,3,5-tribromoindole as the key intermediate.
Bromination of N-carbomethoxyindole employing excess Br2 in
CCl4 allowed the incorporation of bromine atoms at C2, C3,
and C6 in 581.
6.6. Synthesis of Bromophenols
Compared to the synthesis of halogenated terpenes and ACGs,
relatively limited attention was devoted to the synthesis of algal
bromophenols. Recently, Braddock and co-workers reported
the ﬁrst total synthesis of (±)-polysiphenol 680, a naturally
occurring and atropisomerically stable 4,5-dibrominated 9,10-
dihydrophenanthrene, in four steps with 70% overall yield using
commercially available 5-bromoveratraldehyde as starting
material.482 The installation of the two bromine atoms prior
to oxidative coupling prevented further oxidation to a planar
aromatized phenanthrene. In this strategy, the key step was
realized through highly regioselective oxidative coupling of a
dibrominated dihydrostilbene, which was inspired by the
probable biogenesis of polysiphenol. In 1983, Amiya and co-
workers reported a simple synthesis of a series of methyl esters
of tribromophenols from the red alga Symphyocladia latiu-
scla.483 The syntheses involved a one-step bromination
procedure starting from 3,4-dimethoxybenzyl acetate, which,
in turn, was prepared by a standard method from commercially
available vanillin. In 1992, Keehn and co-workers accomplished
the ﬁrst synthesis of the cyclic trimer cyclotribromoveratrylene
(684).484 Treatment of the readily available 5-bromoveratryl
alcohol with triﬂuoroacetic acid at ambient temperature over 3
days yielded 684 as a major product which was readily isolated
with no need for chromatographic separation (Table 5).
7. BIOSYNTHESIS
As discussed above, the marine red algae of the Rhodomelaceae
family have furnished a variety of structurally unique and
sometimes bizarre halogenated metabolites. Understanding of
the metabolic processes leading to these halogenated organic
molecules is still very limited and the biosynthetic pathways for
most of them were not fully elucidated.404,485 There was a great
deal of speculation regarding the biogenesis of these
metabolites,24,486,487 but corroborative experimental evidence
to support most of these hypotheses is limited.
7.1. Biosynthesis of Sesquiterpenes
On the basis of biogenetic considerations, sesquiterpenes
derived from the Rhodomelaceae family can be classiﬁed into
two main groups. The ﬁrst group seems to be arising from six-
membered-ring monocyclic farnesane derivatives, such as
bisabolanes and snyderanes, for which cis,trans-farnesol
pyrophosphate is a logical precursor (Scheme 18).24,486 The
chamigrane skeleton clearly seems to be a key intermediate
system in the construction of the other more complex
sesquiterpenes with various carbon frameworks in this group
(Scheme 18). The second group of the Rhodomelaceae-derived
sesquiterpenes more likely arises from the ten-membered-ring
monocyclic farnesane derivatives, such as germacranes, with
trans,trans-farnesol pyrophosphate as the logical precursor
(Scheme 19).24,486 It is interesting that all seven sesquiterpe-
noid skeletons for which halogenated representatives were not
reported (Figure 22) fall into this group (Scheme 19).
Scheme 18. Plausible Biogenesis of Rhodomelaceae-Derived Sesquiterpenes (Group I)24,486
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Although the proposed transformation processes shown
(Schemes 18 and 19) generally appear to be mechanistically
rational, they are only hypothetical, and alternate pathways are
also possible.
Biogenetic studies have suggested that most brominated
cyclic sesquiterpenes are biosynthesized by a bromonium ion-
induced cyclization of an acyclic terpene precursor, for example,
farnesol, as illustrated in Schemes 18 (or a biological equivalent
thereof).404,431,488 However, except for some biomimetic
studies,489−492 no direct biosynthetic evidence was reported
for metabolic pathways leading to formation of Rhodomela-
ceae-derived halo-sesquiterpenes. In contrast, recent studies of
enzyme-catalyzed halogenation reactions provided some useful
insight into the biogenesis of Rhodomelaceae-derived metab-
olites.429 Among these, vanadium bromoperoxidase (V-BrPO)
is an abundant enzyme that was isolated from many algal
species, including members of the genus Laurencia, and plays a
key role in the biosynthesis of brominated molecules.404 In
2004, the Butler group reported the ﬁrst V-BrPO-catalyzed
asymmetric bromination and cyclization of the sesquiterpene
(E)-(+)-nerolidol (698) to produce α-, β-, and γ-snyderol (172,
173, and 699), as well as the (+)-3β-bromo-8-epicaparrapi
oxide (194) and its stereoisomer 700 (Scheme 20).493 All of
these brominated molecules were isolated from L. obtusa, as
well as from other marine algae, except γ-snyderol (699), which
is a proposed intermediate in the formation of other bicyclic
natural products. This report established for the ﬁrst time the
likely biosynthetic role of V-BrPOs in the production of
brominated cyclic sesquiterpenes from marine red algae.493
7.2. Biosynthesis of C15-Acetogenins
The biosynthesis of C15-acetogenins (cyclic bromoethers) from
red algae was summarized in an excellent review by Murai494
and pioneering works in biosynthetic studies related to
halogenated C15-acetogenins of Rhodomelaceae origin were
carried out by Murai and co-workers.494−498 This biosynthetic
work was outlined in detail in the previous review,494 so the
current review only brieﬂy highlights the most important
progress in this area.
In 1990, the Murai group reported the ﬁrst biosynthetic in
vitro evidence for brominated acetogenins (ACGs) by using
commercially available lactoperoxidase (LPO) and demon-
strated that the linear-chained and highly unstable trans- and cis-
laurediols isolated from Laurencia species were likely to be the
biosynthetic precursors of brominated eight-membered ACGs
of Laurencia origin.495,496 In 1992, the same group described a
single-step, LPO-catalyzed intramolecular cyclization of
(3Z,6S,7S)-laurediol to produce laureatin (481) and its key
intermediate prelaureatin (485).497 The result also suggests
that laurediols are the precursors of Laurencia derived ACGs,
and that LPO has very low substrate speciﬁcity. However, the
conﬁgurations of the vicinal diol units (3E,6S,7S or 3Z,6R,7R)
of laurediols control the pathways leading to either the
laurencin- or laureatin-type products.404 Later in 1994, Murai
and co-workers accomplished the cyclization of (3E,6R,7R)-
and (3Z,6S,7S)-laurediols catalyzed by partially puriﬁed
bromoperoxidase (BrPO) from L. nipponica, in the presence
of H2O2 and NaBr, to produce deacetyllaurencin and
prelaureatin (485) (Scheme 21),498 respectively. Further
reaction of deacetyllaurencin with BrPO yielded bicyclic
ACGs such as laurefucin (465) and laureoxanyne (473)
(Scheme 21).498 These results demonstrated that BrPO is the
enzyme that catalyzes the direct bromo-ether cyclization of
(3E,6R,7R)-laurediol to deacetyllaurencin, and this was the ﬁrst
direct experimental evidence for the possible biosynthetic
pathway leading to the laurencin skeleton.498 These results also
revealed that the geometry of the enyne unit in the substrate
(3E- or 3Z-laurediol) plays an important role in the production
of acetogenins with 7,13-epoxy (e.g., laurefucin 465) or 6,12-
epoxy (e.g., prelaureatin 485) framework (Scheme 21). The
Murai group also investigated the electrophilic bromination of
prelaureatin (485).474 The enzymatic reaction of (Z)-
prelaureatin (485) with LPO or BrPO aﬀorded laureatin
(481) and isolaureatin (482), whereas the reaction of the (E)-
isomer with LPO gave laurallene (510). Although the yields of
brominated ACGs were extremely low, these reactions
established a mechanism of bromonium ion-initiated cyclization
of an acyclic precursor to the eight-membered bromoether
functionality.404
Scheme 19. Plausible Biogenesis of Rhodomelaceae-Derived
Sesquiterpenes (Group II)24,486
Scheme 20. Proposed Mechanism for V-BrPO-Catalyzed
Biosynthesis of α-, β-, and γ-Snyderol (172, 173, and 699),
as well as (+)-3β-Bromo-8-epicaparrapi Oxide (194) and Its
Stereoisomer 700493
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Very recently, radioactive 82Br was used by Seki and co-
workers in an experimental approach to the biosynthetic study
of Laurencia-derived brominated metabolites including lau-
rencin (451) and laureatin (481).485 When cultured in artiﬁcial
seawater medium under 16:8 h (light/dark) illumination cycles
for 24 h, each of the cultured Laurencia strains produced the
species-speciﬁc 82Br-containing metabolites. The work demon-
strated that the use of 82Br provides an eﬀective approach to
investigating the biosynthesis of brominated metabolites in
Laurencia species, though the half-life of 82Br is very short (35.3
h) as compared with those of the more commonly used tracers
14C (5730 y) and 3H (12.3 y).485
8. BIOLOGICAL ACTIVITIES AND FUNCTIONS
8.1. Biological Activities
Halogenated organic molecules from members of the family
Rhodomelaceae not only possess unique structural features but
also exhibit interesting and noteworthy biological properties.
Although no molecules of Rhodomelaceae origin have yet been
successfully developed as commercial medicinal or agro-
chemical agents, some of them exhibit potent biological
activities, such as cytotoxic, antimicrobial, enzyme−inhibitory,
antihelmintic, and antioxidant eﬀects.
8.1.1. Cytotoxic Activity. Cytotoxicity is the most
commonly reported kind of biological activity for halogenated
organic molecules from the family Rhodomelaceae. A
considerable number of such compounds were found to be
cytotoxic to a wide range of cancer cell lines. Bisabolane
sesquiterpenes (5S)-5-acetoxycaespitol (18), (5S)-5-hydroxya-
cetylcaespitol (19), and (5S)-5-acetoxydeoxycaespitol (20), and
the related norterpene (10S*)-10-O-methylfurocaespitanelactol
(275), showed weak cytotoxicity against HT-29, MCF-7, and
A-431 cancer cells, with IC50 values ranging from 11.7 to 91.7
μM.36 The 11,14-cyclized bisabolane peroxide majapolene A
(250) exhibited cytotoxicity toward all 60 cell lines in the NCI
panel with an average GI50 of 0.4 μM, an average TGI of 0.9
μM, and an average LC50 of 2.8 μM.
180 Elatol (55) is a
cytotoxic halosesquiterpene of a type that is characteristic of
this family. This compound exhibited IC50 values of 1.0 μg/mL
to P-388 and 0.1 μg/mL to A-549, HT-29, and MEL-28
cells,103 and values less than 1.0 μg/mL against HM-02, HEP
G2, and MCF-7 cancer cell lines.499 Although 55 is known to
be produced by Laurencia spp.,63 this metabolite, along with
several other similar halosesquiterpenes, was recently isolated
from the sea hare Aplysia dactylomela, which feeds upon
Laurencia. These compounds were evaluated for their in vitro
cytotoxic eﬀects against HeLa and HEP-2 cancer cell lines, and
against nontumoral VERO cells, during both lag- and log-phase
cell growth.500 Elatol (55) was the most active among the
tested compounds under both sets of conditions, with IC50
values of 4.1 and 1.3 μM to HeLa, 2.4 and 2.0 μM to HEP-2,
and 2.3 and 25.0 μM to VERO cells, in lag- and log-phase,
respectively.500 It was also observed that when the cells are
exponentially grown, the activity increases considerably against
HeLa, but not against HEP-2 cells.500 The deschlorinated and
acetylated derivatives of elatol (55), deschloroelatol (81), and
acetyldeschloroelatol (701) (Figure 57) were found to be
inactive in these assays, indicating the relevance of the chlorine
atom to the activity.500 Obtusol (62), an HBr adduct of elatol
(55), was found to be cytotoxic toward MCF-7 and HEP G2
cancer cell lines with IC50 values of 1.5 and <1.0 μg/mL,
respectively.499 Five chamigrane sesquiterpenes isolated from
Laurencia cartilaginea (79, 107, 114, 120, and 121) exhibited
cytotoxicity against four tumor cell lines (P-388, A-549, HT-29,
and MEL-28) with IC50 values ranging from 0.025 to 10 μg/
mL.103 Especially potent activity was observed against HT-29
cells, with IC50’s ranging from 0.025 to 0.5 μg/mL (Table 6).
103
Representatives of two structurally related classes of
halosesquiterpenes, lauranes 144, 166,140 161, 168, 168,137
and 702140 (Figure 57), and cuparanes 122−123137 and 126−
127109 that were isolated from Laurencia microcladia by Kladi
and co-workers, were extensively studied for their cytotoxic
Scheme 21. BrPO-Catalyzed Bromination and Cyclization of
Laurediol to ACGs Laurefucin (465), Laureoxanyne (473),
and Prelaureatin (485).498
Figure 57. Additional halogenated organic molecules for biological evaluation (701−705).
Table 6. Cytotoxicity (IC50, μg/mL) of Chamigrane
Sesquiterpenes 79, 107, 114, 120, and 121103
no. P-388 A-549 HT-29 MEL-28
79 1.0 1.0 0.25 1.0
107 1.0 1.0 0.025 1.0
114 1.0 1.0 0.025 1.0
120 5.0 5.0 0.5 10.0
121 5.0 1.0 0.25 1.0
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activity against several tumor cell lines, and were found to
display a wide range of potency levels.109,137,140 Analysis of the
data indicated that, for laurane and cuparane sesquiterpenes,
neither the cyclopropyl ring nor the trisubstituted double bond
are essential for cytotoxicity. However, the absence of bromine
or hydroxyl functionalities can greatly reduce the activity.140
Although these results are intriguing, more experiments would
be necessary for a detailed SAR analysis of these two classes of
halosesquiterpenes.
The cytotoxicity of brominated parguerane (304−306),
isoparguerane (315), and neoparguerane (316) diterpenes,
along with several chemically derived analogues, was
evaluated.210 These compounds display potent activity against
HeLa and P-388 cells, with IC50 values ranging from 0.3 to 25
μg/mL. It appears that an acetoxy group at C2 and a bromine at
C15 are important for activity, while other acetyl groups are
not.210
Fernańdez and co-workers evaluated 22 halogenated
polyether triterpenes of Laurencia origin for their cytotoxic
activity against tumor cell lines A-549, P-388, HT-29, and
MEL-28.230 Of these, thyrsiferyl 23-acetate (349) displayed the
most potent activity against P-388 cells, with an ED50 of 0.3 ng/
mL,234 while 16-hydroxydehydrothyrsiferol (361) showed the
strongest activity against A-549, HT-29, and MEL-28 cells with
an IC50 of 1.2 μg/mL against each.
230 In addition, 15(28)-
anhydrothyrsiferyl diacetate (351), 15-anhydrothyrsiferyl diac-
etate (352), and magireols A−C (353−355) demonstrated
potent cytotoxicity against P-388 tumor cells, with ED50 values
of 50 and 100 ng/mL respectively, for 351 and 352, and 30 ng/
mL for 353−355.235 Callicladol (356) displayed in vitro
cytotoxic activity against P-388 murine leukemia cells with an
IC50 of 1.75 μg/mL.
236 21α-Hydroxythyrsiferol (367) and
laurenmariannol (368) also showed cytotoxicity toward P-388
with IC50 values of 6.6 and 0.60 μg/mL, respectively.
243 Further
examination revealed that thyrsiferyl 23-acetate (349) induced
rapid cell death in various leukemic T- and B-cell lines, and that
the cell death follows a typical apoptotic process.501 Thyrsiferol
(347) inhibited hypoxia-inducible factor-1 (HIF-1) activation
in T47D human breast tumor cells.502 Moreover, dehydro-
thyrsiferol (350), 22-hydroxy-15(28)-dehydrovenustatriol
(358), iubol (359),239 prethyrsenol A (373), 15-dehydrox-
ythyrsenol A (378), and 13-hydroxyprethyrsenol A (374)246
were found to be toxic to Jurkat, MM-144, HeLa, and CADO-
ES-1 cancer cell lines with IC50 values ranging from 2.0 to 30.0
μM.
The halogenated C15-acetogenin laurefurenyne F (471)
exhibited moderate nonselective cytotoxicity against three
solid tumor cell lines (murine colon 38, human colon H116,
and human lung H125), leukemia L1210, and human normal
cells CFU-GM.302 Structure−activity relationship analysis
showed that laurefurenyne F (471) was more active than its
C3 cis isomer, laurefurenyne E (470), which showed very weak
cytotoxicity against murine colon 38 only. Additionally,
bromoine-substitution at C12 was deduced to be a key feature
for the cytotoxicity of laurefurenyne F (471), as evidenced by
comparison with its C12-hydroxylated derivative, which showed
no activity against the tested cells.302
Apart from the cytotoxic haloterpenes and C15-acetogenins,
some haloindoles from these algae also proved to be active in
cytotoxicity assays. 2,3,5,6-Tetrabromoindole (573) showed
cytotoxicity against L1210 tumor cells (ID50 3.6 μg/mL),
354
while the sulfur-containing polybromobisindoles 595 and 596
were reported to possess cytotoxicity against HT-29 and P-388
tumor cells, respectively.356 Additionally, some phenylethanol-
derived bromophenols (620−622 and 655) showed moderate
cytotoxicity against ﬁve tumor cell lines (A-549, A-2780, Bel-
7402, BGC-823, and HCT-8) with IC50 values ranging from 9.4
to 20.8 μg/mL.368 Bromophenols 649 and 650 showed activity
against Hela cancer cell line, with IC50 values of 8.71 and 9.61
μg/mL, respectively.503
8.1.2. Antibacterial Activity. The halosesquiterpene elatol
(55) inhibited six species of human pathogenic bacteria, with
particularly potent eﬀects against Staphylococcus epidermis,
Klebsiella pneumoniae, and Salmonella sp. The potency observed
was as good as or better than six standard, commercial available
antibiotics (augmentin, latamoxef, ceﬂaclor, ceftriaxone, kana-
mycin, and netilmicin).504 In the same study, iso-obtusol (64)
exhibited antibacterial activity against four bacteria with
especially noteworthy activities against K. pneumoniae and
Salmonella sp.504 Further experiments demonstrated that both
compounds displayed bacteriostatic rather than bactericidal
eﬀects.504 While brominated diterpene 10-acetoxyangasiol
(289) exhibited antibacterial activity against Vibrio cholerae
with MIC 100 μg/mL,194 the bromoditerpene 10-hydroxyka-
hukuene B (341) displayed weak antibacterial activity against
Staphylococcus aureus, and this compound as well as the ACG
derivative laurenmariallene (433) exhibited weak activity
against Escherichia coli.67 Recently, ACG derivatives 455 and
458−460 were reported to have antistaphylococcal activity
against a panel of multidrug and methicillin-resistant S. aureus
strains with MICs ranging from 8 to 256 μg/mL.297 Among
these compounds, 458 was found to be the most active, with
MIC values of 8−16 μg/mL. The presence of two acetyl groups
in 458 may play a key role in improving its cellular
bioavailability by making the species more lipophilic.297
Bromophenols 649−652 and 674 were evaluated for
antibacterial activity against eight strains of Gram-positive (S.
aureus ATCC29213, S. aureus 02-60, S. epidermidis
ATCC12228, and S. epidermidis 02-4) and Gram-negative (E.
coli ATCC25922, E. coli 02-26, Pseudomonas aeruginosa
ATCC27853, and P. aeruginosa 02-29) bacteria.384 Of these,
compound 674 showed potent inhibitory activity against seven
out of eight strains, especially against S. epidermidis
ATCC12228, whereas 650 displayed moderate activity against
four strains.384 More recently, bromophenol 649 was reported
to have activity against ﬁve bacterial strains (S. aureus
ATCC6538p, Bacillus subtilis ATCC 6633, Micrococcus luteus
IFC 12708, Proteus vulgaris ATCC3851, and S. typhimurium
ATCC 14028) with MIC values ranging from 25 to 50 μg/
mL.505 At a level of 100 μg per 12.7 mm disc, 2,3,5,6-
tetrabromoindole (573) displayed an inhibition zone of 16 mm
against Bacillus subtilis after 24 h of growth.354
The crude extract of Laurencia pannosa exhibited anti-
bacterial activity against three out of 13 species of marine
bacteria isolated from algal habitats in Malaysian waters. Three
of these species (Chromobacterium violaceum, Proteus mirabilis,
and Vibrio cholerae) were then used to evaluate the antibacterial
activity of two halosesquiterpenes, pannosanol (247) and
pannosane (248), as well as an ACG derivative, (3Z)-
chlorofucin (468), that were isolated from L. pannosa.178 The
major metabolite pannosanol (247) exhibited antibacterial
activity against all of the tested bacteria with MIC values of 60
μg/disc against P. mirabilis and 100 μg/disc against C. violaceum
and V. cholerae, while pannosane (248) and (3Z)-chlorofucin
(468) displayed activity only against C. violaceum with MIC
values of 60 and 100 μg/disc, respectively.178 A subsequent
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report by the same authors indicated that the halosesquiterpene
elatol (55) from L. majuscula displayed activity against all 13
marine bacteria, with MIC values of 5, 5, and 10 μg/disc against
Clostridium cellobioparum, P. mirabilis, and Flavobacterium
helmiphilum, and 15−30 μg/disc against the remaining
bacteria.349 In addition, the halosesquiterpene iso-obtusol
(64) showed MIC values of 10 and 15 μg/disc against C.
cellobioparum and P. mirabilis and 40−60 μg/disc against the
other bacteria, whereas the acetogenin lembyne A (558)
displayed weaker antibacterial activity with MIC values ranging
from 20 to 60 μg/disc.349
Halogenated organic molecules from several Okinawan
Laurencia species were evaluated for activity against eight
marine bacteria, and the results indicated that the sesquiter-
penes deschloroelatol (81), iso-laurinterol (142), and laur-
interol (166), as well as the acetogenin (12E)-lembyne (559),
displayed activity when tested in the range of 3−30 μg/disc.96
The brominated diterpene neoirietetraol (336) exhibited
inhibitory activity against two of six species of bacterial isolates
tested, Alcaligenes aquamarinus and E. coli, at 100 μg/disc.225
The halochamigranes elatol (55), iso-obtusol (64), 10,15-
dibromo-1,3(15),7(14)-chamigratrien-9-ol (107), and (3E)-
bromomethylidene-10β-bromo-β-chamigrene-9β-ol (114) dis-
played antibacterial activity against“ice-ice” disease pathogens
Alteromonas sp1., Alteromonas sp2., Proteus mirabilis, Proteus sp.,
Cytophaga−Flavobacterium, and Vibrio sp..506 The above results
suggest that halogenated molecules may play ecological roles in
defending the algae against the intrusion of pathogenic marine
bacteria.
8.1.3. Antifungal Activity. The halosesquiterpenes elatol
(55) and deschloroelatol (81) displayed moderate antifungal
properties toward Mycotypha microspora and Eurotium repens.75
In addition, the bromophenol bis(2,3,6-tribromo-4,5-
dihydroxybenzyl)ether (675) exhibited in vitro activity below
the 50 μg/mL level against Aspergillus niger and four other
fungal species.390 At a level of 100 μg per 12.7 mm disc, 2,3,5,6-
tetrabromoindole (573) displayed an inhibition zone of 16 mm
against Saccharomyces cerevisiae after 24 h of growth.354 More
recently, bromophenol 649 was reported to have potent activity
against four fungal strains with MIC values ranging from 0.78 to
1.56 μg/mL.505
8.1.4. Antiviral Activity. Various halosesquiterpenes
including pacifenol (29), johnstonol (30), nidiﬁcene (57),
and nidiﬁdienol (59) from L. nidif ica, were found to possess
antiviral activity against Herpes 1-type (HSV-1).85 Of these,
compounds 57 and 59 have good activity with IC50 values of
1.5 and 2.4 μg/mL, respectively. The exo-methylene group was
suggested to be a factor in the antiviral activity.85 The crude
extract of L. venusta displayed signiﬁcant activity against HSV-1
and vesicular stomatitis virus (VSV). Activity-guided fractiona-
tion led to the separation of the active components, which
included thyrsiferol (347), venustatriol (348), and thyrsiferyl-
23 acetate (349).233
8.1.5. Enzyme−Inhibitory Activity. The polyether
triterpene thyrsiferyl 23-acetate (349) displayed potent and
selective inhibitory activity against serine/threonine protein
phosphatase 2A (PP2A) with IC50 values of 4−16 μM
depending on the enzyme concentration.507 Bromophenols
600, 672, and 674 from Odonthalia corymbifera were found to
be inactivators of α-glucosidase.389 Bromophenols 633−634,
659−660, and 676 exhibited signiﬁcant aldose reductase
inhibitory activity with IC50 values ranging from 0.11 to 1.15
μg/mL, and the eﬀect was similar to (633) or higher than (634,
659−660, and 676) that of the positive control (quercetin).373
The bromophenols vidalols A (664) and B (685) are anti-
inﬂammatory agents that act through inhibition of phospholi-
pase A2, causing 96% inactivation at 1.6 μg/mL.
386 However, it
was diﬃcult to maintain the purity of vidalols A and B during
the bioassay, so it was not clear whether the inhibitory activity
was caused by the compounds themselves or by degradation
products thereof.386 The bromophenol 5′-hydroxyisoavrainvil-
leol (703) (Figure 57), isolated from both a green alga
Avrainvillea nigricans508 and the red alga Polysiphonia
urceolata,509 exhibited potent inhibition of protein tyrosine
phosphatase 1B (PTP1B) with an IC50 of 4.9 μM.
509
Bromophenols 631, 659, and 666 obtained from Symphyocladia
latiuscula also displayed strong activity against PTP1B with IC50
of 3.9, 4.3, and 3.5 μM, respectively.510 Brominated derivatives
663 and 673 from L. similis also inhibited PTP1B with IC50
values of 2.66 and 2.97 μM, respectively.385
8.1.6. Radical Scavenging Activity. A number of
bromophenols reportedly display signiﬁcant antioxidant and
radical scavenging activity. Compounds 630 and 635 showed
scavenging activities of DPPH radicals with IC50 values of 7.5
and 8.5 μM, respectively, and were approximately 2-fold more
potent than L-ascorbic acid in the assay.374 Polybrominated
mono- and bis-phenols, including 631, 633, 634, 645, 646, 659,
661, 666, and 675 from Symphyocladia latiuscula380 and 647,
648, 667,381 678, 679, 681,391 682,393 and 688397 from
Polysiphonia urceolata were also evaluated for the ability to
scavenge DPPH free radicals. All were found to show potent
activity, with IC50 values ranging from 6.1 to 24.7 μM,
compared to the known positive control BHT, which had an
IC50 83.8 μM in the assay (Table 7). More recently, six new
brominated monophenols (607, 611−614, and 616) isolated
from Rhodomela confervoides were reported to possess potent
antioxidant activity against DPPH (with IC50 7.4−50.6 μM,
Table 7) and ABTS radicals (with TEAC 1.60−3.68 mM).366
Generally, the DPPH radical-scavenging eﬀects of the bis-
phenols are stronger than those of the monophenols,
suggesting that the free-radical-scavenging activities of these
phenolic compounds are correlated with the number of
Table 7. DPPH Radical Scavenging Activity (IC50 values in
μM) of Brominated Mono- and Bisphenols
no. IC50 ref no. IC50 ref
600 42.3 366 634 24.7 460
601 40.5 366 645 18.5 460
602 32.0 366 646 24.0 460
605 26.3 366 647 9.7 381
606 30.2 366 648 16.1 381
607 50.6 366 659 8.1 440
608 18.6 366 661 10.5 440
611 9.5 366 666 10.2 440
612 7.4 366 667 21.9 381
613 20.5 366 675 8.5 440
614 19.8 366 678 6.8 391
615 7.6 366 679 6.1 391
616 8.7 366 681 8.1 391
620 30.9 366 682 15.1 391
625 50.9 366 688 7.9 397
631 15.5 440 BHTa 83.8 391, 397
633 14.0 440
aBHT = butylated hydroxytoluene (positive control).
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hydroxyl groups in the molecules.380 Replacement of an OH
group with an OMe group on the aromatic ring signiﬁcantly
decreased the activity.366 Meanwhile, the number and position
of the bromine atoms are also important factors contributing to
the variation in DPPH scavenging activity observed for the
compounds in this class.366
8.2. Biological Functions
Halogenated molecules from Rhodomelaceae were speculated
to possess multiple biological functions based on laboratory
assay results. Numerous reports have shown that such
metabolites can act as antifeedant, insecticidal, antifouling,
and allelopathic agents, implying possible roles in the defense
systems of Rhodomelaceae.
8.2.1. Antifeedant Activity. Chemical defense against
herbivores is proposed to be the most important role among all
the biological functions of halogenated molecules.410 Sea hares
of the genus Aplysia (phylum Mollusca) are well-known to feed
on Laurencia species. Numerous dietary halogenated structures,
such as the sesquiterpenes prepacifenol acetate (53),62
prepacifenol epoxide (54),44 laurenisol acetate (137),119 and
aplysistatin (199),151 as well as the triterpene derivative aurilol
(388),252 were reported from both sea hares and their algal
diets, and some of these compounds display toxicity to cell lines
and/or brine shrimp in laboratory assays.62,500,511 The
occurrence of algal dietary toxins in sea hares does not prove
a defensive function. However, it is interesting that some of
these halogenated molecules were found in less toxic acetylated
forms in sea hares.500 This observation led to a hypothesis that
sea hares use acetylation as a simple means of storing toxic
metabolites acquired through the diet.397 Additionally, some
grazers such as sea hares may be partly acclimatized to these
active molecules, for example, palisadins A (195) and B (196)
from L. obtusa,512 and even use them to defend against their
own predators.511,512
Defensive eﬀects of halogenated molecules have also been
suggested by direct antifeedant assays. A halosesquiterpene of
the chamigrane class, pacifenol (29), exhibited antifeedant
activity against the aphid Schizaphis graminum,513 while the
halogenated diterpenes deoxyparguerol (302), 2-deacetoxy-
deoxyparguerol (306), and parguerol triacetate (704) (Figure
57) displayed potent feeding-deterrent activity against the
young abalone Huliotis discus hannai.409 A series of
bromophenols including 600, 601, 649, 650, and 665 was
also revealed to have potent feeding-deterrent activity in the
same assay.387 Further experiments revealed that 302, 704,409
and 649−650387 signiﬁcantly deterred feeding by two diﬀerent
species of young sea urchins (Strongylocentrotus nudus and S.
intermedius). When coated on the palatable sea grass Thalassia
testudinum and placed on coral reefs, the bromophenol vidalol
A (664) signiﬁcantly reduced grazing by Caribbean herbivorous
ﬁshes, suggesting that it is a potent defensive agent against
marine herbivores.386 The natural concentration of the crude
organic extract of L. obtusa signiﬁcantly inhibited feeding by
two herbivores (the crab Pachygrapsus transversus and the
urchin Lytechinus variegates).514 This apparent defensive action
was found to be due to elatol (55), which was the major
constituent of the extract.514 Further experiments demonstrated
that the antifouling property of chemicals produced by L. obtusa
could make this alga less attractive to ﬁsh grazing. Other
experimental evidence reinforces the idea that marine natural
products may have a variety of similar functions in the sea.514
8.2.2. Insecticidal Activity. The chamigrane sesquiterpene
deoxyprepacifenol (96) and the acetogenins (Z)-laureatin
(481) and (Z)-isolaureatin (482) exhibited strong insecticidal
activity against larvae of the mosquito Culex pipiens pallens with
IC50 values of 0.06−0.50 ppm and LC50 values of 2.86−6.83
ppm,87 while the chamigrane sesquiterpenes pacifenol (29),
2,10-dibromo-3-chloro-α-chamigrene (49), prepacifenol acetate
(53), and deoxyprepacifenol (96), displayed strong to
moderate toxicity to brine shrimp (Artemia salina).62 Similarly,
the haloditerpene neoirietetraol (336) and the acetogenin
(3Z)-laurenyne (499) showed toxicity toward brine shrimp
with LC50 values of 40.1 and 467.0 μM, respectively.
225
The acetogenins (3Z)-13-epilaurencienyne (490), (3E)-
epipinnatiﬁdenyne (491), (3E)-9-chloro-13-bromo-6:12-
epoxy-7,10-diacetoxypentadec-3-en-1-yne (492), and its 3Z
isomer (493) exhibited toxicity to ants (Pheidole pallidula),
with the cis isomers (490 and 493) showing stronger activity
than the trans isomers (491 and 492).318 More recently, the
acetogenin (12E)-cis-maneonene E (555) was reported to have
larvicidal activity against two economically important pests,
Tribolium confusum and Culex pipiens.347
8.2.3. Antifouling Activity. The chamigrane sesquiter-
penes elatol (55) and deschloroelatol (81) were found to be
responsible for the observed antifouling activity of the CH2Cl2
extract of L. rigida.75,515 At a concentration of 100 ng/cm2,
elatol (55) completely inhibited the settlement of larvae of the
barnacle Balanus amphitrite, and deschloroelatol (81) reduced it
by 90%. Both compounds also deterred settlement of larvae of
the bryozoan Bugula neritina at low concentrations. However,
these metabolites act by being toxic and severely aﬀecting the
survival rate of nauplii larvae of B. amphitrite. Thus, commercial
development of 55 or 81 as antifouling agents is unlikely.75,515
The crude extract of L. caduciramulosa, from which the three
halosesquiterpenes pacifenol (29), ﬁliformin (152), and
allolaurinterol (138) and two nonhalosesquiterpenes were
identiﬁed, exhibited signiﬁcant antifouling activity against
mussel attachment.516
8.2.4. Allelopathic Activity. Two halosesquiterpenes,
(−)-10α-bromo-9β-hydroxy-α-chamigrene (74) and deschlor-
oelatol (81), from the red alga L. rigida showed moderate
antialgal activity against the green alga Chlorella fusca.75 The
bromophenols 5-bromoprotocatechualdehyde (598) and lan-
osol (600) were also toxic to some unicellular marine algae,
such as Skeletonema costatum and Olisthodiscus species,517 while
another report indicated that lanosol (600) could strongly
stimulate the growth of the red algae Goniotrichum alsidii and
PoIysiphonia urceolata, but inhibited the growth of P. urceolata
at a higher concentration of 0.2 mM.518 Dibromocatechol α-O-
methyllanosol (601) exhibited a stimulating eﬀect on the
growth and elongation of terrestrial plants in both in vivo and
in vitro systems.519
8.3. Miscellaneous Activity
In vitro anthelmintic assays revealed that halosesquiterpenes of
the bisabolane class (6)29 and the chamigrane class (67, 75−77,
80, and 120)76 displayed moderate antiparasitic activity against
Nippostrongylus brasiliensis, while snyderane sesquiterpene 176
exhibited moderate antimalarial activity against the D6 and W2
clones of Plasmodium falciparum with IC50 values of 2700 and
4000 ng/mL, respectively.142 Halosesquiterpenes elatol (55)
and obtusol (62) were recently reported to have in vitro and in
vivo antileishmanial activity against promastigote and amasti-
gote forms of Leishmania amazonensis.520,521 After 72 h of
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treatment, elatol (55) showed signiﬁcant antileishamanial
activity, with IC50 values of 4.0 and 0.45 μM for promastigote
and intracellular amastigote forms of L. amazonensis,
respectively, and the compound also induced notable changes
in the ultrastructure of the mitochondrion of the parasite.521
These results suggested that elatol (55) may have important
advantages for the development of new antileishamanial
chemotherapies. Recently, the bromoditerpene neorogioltriol
(344) was reported to possess analgesic and in vitro and in vivo
anti-inﬂammatory activities,229,522 while acetogenins (12E)-cis-
maneonene E (555) and (12Z)-cis-maneonene D (557) were
found to have potential to regulate programmed death in the
initiation and propagation of inﬂammatory responses.348
Several bromophenols including 600, 601, 649−651, and 705
(Figure 57) isolated from Odonthalia corymbifera were
demonstrated to possess potent inhibitory activity against
isocitrate lyase (ICL), a key enzyme in the glyoxylate cycle, as
well as in the rice fungal pathogen Magnaporthe grisea.523 In
addition, as ICL inhibitors, these compounds may be promising
candidates for crop protection, particularly to protect rice
plants against M. grisea.523
8.4. Summary of Biological Activities and Functions
As discussed above, many halogenated organic molecules not
only have intriguing molecular structures but also possess a
variety of biological activities including cytotoxic, antimicrobial,
enzyme−inhibitory, and radical scavenging eﬀects, as well as
potential ecological relevant functions, such as antifeedant,
insecticidal, antifouling, and allelopathic activity. Despite the
above positive results, however, biological evaluations of these
molecules have typically been limited to one or two bioassay
models, and many of them, especially the diterpenes and
acetogenins, lack any reported bioassay data. Therefore, much
more extensive testing of these molecules seems warranted.
Further investigation of the structure−activity relationships,
especially the eﬀects of the halogen atoms on the bioactivity as
well as mode-of-action studies, could result in the discovery of
more promising analogues with potential clinical application.
For safety considerations, however, the possible toxicity of
these halogenated organic molecules or analogues should be
evaluated before implementing any use as a drug candidate or
as a dietary supplement.
9. PROSPECTS FOR FUTURE DISCOVERIES AND
CONCLUDING REMARKS
A total of 697 halogenated organic molecules isolated in the
past several decades from algal species of the family
Rhodomelaceae were covered in this review. The majority of
these compounds contain bromine, with some of them
containing both bromine and chlorine. Relatively few contain
only chlorine and even fewer contain iodine. Since seawater is a
halogen-rich environment, it is not surprising that marine algal
species are capable of incorporating halogen atoms into the
organic molecules that they produce. However, it is remarkable
that brominated compounds reported from the Rhodomelaceae
to date are more abundant than chlorinated compounds from
such sources, in spite of the fact that seawater contains a much
higher concentration of chloride ion (19 000 mg/L) than
bromide ion (65 mg/L).524 The selective incorporation of
bromine during the biosynthesis of halogenated metabolites in
these algal species oﬀers a very interesting topic for future
study. Resolving questions about the biosynthetic pathways of
halogenated organic molecules remains an important challenge,
as it is intimately connected to understanding the evolutionary
and natural roles of such compounds in these algae. On the
other hand, marine algae are directly exposed in the marine
environment and are aﬀected by symbiotic and/or ambient
microorganisms, such as bacteria, fungi, or viruses. However,
the impact of these microorganisms on the production of the
halogenated organic molecules by marine algae remains unclear
so far. A deeper insight in mutualistic symbiosis involving the
metabolites of marine algae is therefore of a great interesting
subject for the future study.
Although the biological activities and ecological functions of
halogenated organic molecules were studied to some degree,
little is known regarding their structure−activity relationships.
Further studies in this area could contribute to a better
understanding of their mechanisms of action at the cellular and
molecular level, which would be beneﬁcial in the ongoing
development and structure optimization of this class of
compounds, and could lead to the discovery of novel
pharmacophores and heretofore unidentiﬁed mechanisms of
drug action. On the other hand, development of new strategies
and eﬃcient methods for the synthesis of halogenated organic
molecules are also necessary in light of the fascinating
structures and intriguing biological properties displayed by
such compounds, as well as the diﬃculties in obtaining large
quantities of them from the natural sources.
The Rhodomelaceae constitute a large algal family, and
species in this family are distributed worldwide.525 On the basis
of hit rates in the species of the family so far examined, and, as a
fact that, the chemical constituents of the species in the family
especially in the genus Laurencia displayed a marked variation,
which often seems to be dependent upon the growth locality
and collection season, it could be predicted that hundreds or
thousands of new halogenated organic molecules with
signiﬁcant biological activity await discovery. Although at
present we cannot comment further on the importance of
halogenated organic molecules from the Rhodomelaceae, given
their many biological activities, it would be not surprising if
some of these compounds or their synthetic analogues
eventually ﬁnd practical application in medicine or agriculture.
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A-2780 human ovarian cancer cell line
A-431 human epidermoid carcinoma cell line
A-549 human lung carcinoma cell line
ABTS 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic
acid)diammonium salt
ACG acetogenin
9-BBN 9-borabicyclo[3.3.1]nonane dimer
t-BDMS-Cl tert-butyldimethylsilyl chloride
Bel-7402 hepatoma cell line
BGC-823 stomach cancer cell line
BHT butylated hydroxytoluene
BrPO bromoperoxidase
CADO-ES-1 Ewing’s sarcoma cell line
CD circular dichroism
D-DET D-(−)-diethy tartrate
DIBAL-H diisobutylaluminium hydride
DME 1,2-dimethoxyethane
DMS dimethylsulﬁde
DPPH α,α-diphenyl-β-picrylhydrazyl
ED50 median eﬀective dose
GI50 50% growth inhibition
HCT-8 human colon cancer cell line
HeLa human carcinoma of the cervix cell line
HEP-2 human carcinoma of the larynx cell line
HEP G2 liver carcinoma cell line
HIF-1 hypoxia-inducible factor-1
HM-02 gastric carcinoma cell line
HMPA hexamethylphosphoramide
HT-29 human colon carcinoma cell line
IEEA intramolecular ester enolate alkylation
Jurkat T-cell acute leukemia cell line
L1210 mouse lymphocytic leukemia cell line
LC50 50% cell death
LDA lithium diisopropylamide
LiHMDS lithium hexamethyldisilazide
LPO lactoperoxidase
MCF-7 breast carcinoma cell line
MEL-28 human melanoma cell line
MIC minimum inhibitory concentration
MM-144 multiple myeloma cell line
MOMCl chloromethyl methyl ether
MTPA 2-methoxy-2-(triﬂuoromethyl)phenylacetic acid
NBS N-bromosuccinimide
NMR nuclear magnetic resonance
n-Oct3P trin-octylphosphine
NOESY nuclear Overhauser enhancement spectroscopy
P-388 murine lymphoid neoplasm
PCC pyridinium chlorochromate
PDC pyridinium dichromate
PMB p-methoxybenzyl
p-TSA p-toluenesulfonic acid
SAR structure−activity relationship
SEM 2-(trimethylsilyl)ethoxymethyl
T47D human breast tumor cell line
TBAF tetrabutylammonium ﬂuoride
TBCD 2,4,4,6-tetrabromocyclohexa-2,5-dienone
TBDPS tert-butyldiphenylsilyl
TEAC trolox equivalent antioxidant capacity
TES triethylsilyl
TGI total growth inhibition
THP tris(hydroxy-methyl)phosphine
TIPS triisopropylsilyl
TPT titanium isopropoxide
V-BrPO vanadium bromoperoxidase
VERO African green monkey kidney cell line
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D.; Peŕez, C. Tetrahedron Lett. 1976, 17, 3051.
(65) Waraszkiewicz, S. M.; Erickson, K. L. Tetrahedron Lett. 1974, 15,
2003.
(66) Waraszkiewicz, S. M.; Erickson, K. L. Tetrahedron Lett. 1975, 16,
281.
(67) Ji, N. Y.; Li, X. M.; Li, K.; Ding, L. P.; Gloer, J. B.; Wang, B. G. J.
Nat. Prod. 2007, 70, 1901.
(68) McMillan, J. A.; Paul, I. C.; White, R. H.; Hager, L. P.
Tetrahedron Lett. 1974, 15, 2039.
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(214) Gonzaĺez, A. G.; Ciccio, J. F.; Rivera, A. P.; Martín, J. D. J. Org.
Chem. 1985, 50, 1261.
(215) Estrada, D. M.; Ravelo, J. L.; Ruiz-Peŕez, C.; Martín, J. D.;
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(451) Gonzaĺez, I. C.; Forsyth, C. J. J. Am. Chem. Soc. 2000, 122,
9099.
(452) Corey, E. J.; Ha, D. C. Tetrahedron Lett. 1988, 29, 3171.
(453) Tanuwidjaja, J.; Ng, S. S.; Jamison, T. F. J. Am. Chem. Soc.
2009, 131, 12084.
(454) Morimoto, Y.; Okita, T.; Takaishi, M.; Tanaka, T. Angew.
Chem., Int. Ed. 2007, 46, 1132.
(455) Andrey, O.; Glanzmann, C.; Landais, Y.; Parrarapado, L.
Tetrahedron 1997, 53, 2835.
(456) Chandler, C. L.; Phillips, A. J. Org. Lett. 2005, 7, 3493.
(457) Osumi, K.; Sugimura, H. Tetrahedron Lett. 1995, 36, 5789.
(458) Lee, E.; Yoo, S. K.; Cho, Y. S.; Cheon, H. S.; Chong, Y. H.
Tetrahedron Lett. 1997, 38, 7757.
(459) Boukouvalas, J.; Fortier, G.; Radu, I. I. J. Org. Chem. 1998, 63,
916.
(460) Mereyala, H. B.; Gadikota, R. R. Tetrahedron: Asymmetry 2000,
11, 743.
(461) García, C.; Martín, T.; Martín, V. S. J. Org. Chem. 2001, 66,
1420.
(462) Gadikota, R. R.; Callam, C. S.; Lowary, T. L. J. Org. Chem.
2001, 66, 9046.
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